<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ital J Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Ital J Pediatr</journal-id><journal-title-group><journal-title>Italian Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">1824-7288</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4239406</article-id><article-id pub-id-type="pmid">25928129</article-id><article-id pub-id-type="publisher-id">92</article-id><article-id pub-id-type="doi">10.1186/s13052-014-0092-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Pediatric migraine and episodic syndromes that may be associated with migraine</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spiri</surname><given-names>Daniele</given-names></name><address><email>danielespiri@libero.it</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Rinaldi</surname><given-names>Victoria Elisa</given-names></name><address><email>victoria.rinaldi87@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Titomanlio</surname><given-names>Luigi</given-names></name><address><email>luigi.titomanlio@rdb.aphp.fr</email></address><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff4"/><xref ref-type="aff" rid="Aff5"/></contrib><aff id="Aff1"><label/>Department of Pediatrics, Luigi Sacco Hospital, Universit&#x000e0; degli Studi di Milano, Milan, Italy </aff><aff id="Aff2"><label/>Department of Pediatrics, Universit&#x000e0; degli Studi di Perugia, Perugia, Italy </aff><aff id="Aff3"><label/>Department of Pediatric Emergency Care, APHP-Hospital Robert Debr&#x000e9;, Paris, France </aff><aff id="Aff4"><label/>Pediatric Migraine and Neurovascular Diseases Unit, APHP-Hospital Robert Debr&#x000e9;, Paris, France </aff><aff id="Aff5"><label/>Pediatric Emergency Department, Robert Debr&#x000e9; University Hospital, 48, Bld S&#x000e9;rurier, Paris, 75019 France </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>40</volume><elocation-id>92</elocation-id><history><date date-type="received"><day>1</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; Spiri et al.; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Importance</title><p>Migraine is a common disorder and a frequent cause of medical consultation in children. Many childhood episodic syndromes have been described as common precursors of migraine.</p></sec><sec><title>Objective</title><p>To review current knowledge on migraine and childhood episodic syndromes, and to discuss future directions for research and clinical practice.</p></sec><sec><title>Findings</title><p>For most children it is difficult to describe a headache and fully verbalize symptoms such as photophobia and phonophobia that must be inferred from behaviour. Classical migraine features are rare before the age of 6 years, but some migraine-related syndromes have been described. Benign paroxysmal torticollis of infancy, benign paroxysmal vertigo of childhood, cyclic vomiting syndrome and abdominal migraine are currently classified as childhood episodic syndromes, and therefore common precursors of migraine. A strong association between infantile colic and migraine has recently been reported. There are similarities between children with episodic syndromes and children with migraine, regarding social and demographic factors, precipitating and relieving factors, and accompanying gastrointestinal, neurologic, and vasomotor features. The real pathophysiological mechanisms of migraine are not fully understood. Current data obtained through molecular and functional studies provide a complex model in which vascular and neurologic events cooperate in the pathogenesis of migraine attacks. Genetic factors causing disturbances in neuronal ion channels, make a migraineur more sensitive to multiple trigger factors that activate the nociception cascade. The expanding knowledge on migraine genetics and pathophysiology may be applicable to childhood episodic syndromes. Migraine preventive strategies are particularly important in children, and could be beneficial in childhood episodic syndromes. Nonspecific analgesics like ibuprofen and acetaminophen are widely used in pediatrics to control pain and have been found to be effective also in the treatment of acute migraine attacks. Triptans are the specific fist-line drugs for acute migraine treatment.</p></sec><sec><title>Conclusions and relevance</title><p>Migraine phenotype differs somewhat in the developing brain, and childhood episodic syndromes may arise before typical migraine headache. Diagnosing pediatric migraine may be difficult because of children&#x02019;s language and cognitive abilities. The risk of underestimating migraine in pediatric age is high. An adequate diagnosis is important to maintain a good quality of life and to avoid inappropriate therapy.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Infantile colic</kwd><kwd>Migraine</kwd><kwd>Cyclic vomiting</kwd><kwd>Recurrent abdominal pain</kwd><kwd>Functional abdominal pain</kwd><kwd>Torticollis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Headache is the most common pain condition in children and adolescents visiting a pediatrician [<xref ref-type="bibr" rid="CR1">1</xref>] and migraine is one of the most common causes of primary headache in childhood [<xref ref-type="bibr" rid="CR2">2</xref>]. Its prevalence increases throughout childhood, affecting 1-3% of 3 to 7 year-olds, 4-11% of 7 to 11 year-olds, and 8-28% of teenagers (13-18 years old) [<xref ref-type="bibr" rid="CR3">3</xref>]. Migraine is a neurovascular disorder with a genetic background and several genes have been identified as being direct causal or associated agents [<xref ref-type="bibr" rid="CR4">4</xref>]. First degree relatives of subjects with migraine have a 1.9 times higher risk of developing migraine compared to the general population [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>] and the concordance rate for migraine with aura in monozygotic twins is 34% compared to 12% in dizygotic twins [<xref ref-type="bibr" rid="CR7">7</xref>], suggesting the importance of genetic factors in migraine development.</p><p>Migraine is disabling at all ages; in children and adolescents it can be accompanied by significant disability, such as school absenteeism, low-quality performance and impaired emotional functioning [<xref ref-type="bibr" rid="CR8">8</xref>]. Children with recurrent headache can suffer from depression, anxiety and often from sleep disorders and they have the tendency to feel dizzy [<xref ref-type="bibr" rid="CR9">9</xref>]. Poor performance at school is more likely to be present in children with episodic and chronic migraine, in comparison to children without headaches. School performance is significantly influenced by severity and duration of headache attacks, by abnormal scores of mental health, and by nausea, as well as by headache frequency and use of analgesics [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>We aimed at reviewing current knowledge and concerns on migraine and related episodic syndromes. To identify articles a literature search was carried out in PubMed and the electronic Science Direct for all studies published until July 31<sup>st</sup>, 2014. The keywords searched for were &#x0201c;migraine and children&#x0201d;, &#x0201d;headache and children&#x0201d;, and &#x0201c;episodic syndromes and migraine&#x0201d;. Studies were included if they focused on the pediatric population, if they were published in peer reviewed journals and written in English.</p><sec id="Sec2"><title>Migraine diagnosis and current state of clinical practice</title><p>Headache diagnosis is usually conducted on the basis of the International Headache Society (IHS) criteria. After two editions (respectively in 1988 and in 2004) [<xref ref-type="bibr" rid="CR11">11</xref>] the latest International Classification of Headache Disorders (ICHD-III beta) is available [<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec3"><title>Diagnostic International Headache Society criteria for migraine without aura and migraine with aura</title><p><bold>Migraine without aura</bold><list list-type="simple"><list-item><label>A.</label><p>At least 5 attacks fulfilling criteria B-D</p></list-item><list-item><label>B.</label><p>Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated). In children, attacks may last 2-72 hours.</p></list-item><list-item><label>C.</label><p>Headache has at least two of the following characteristics:<list list-type="order"><list-item><p>unilateral location (commonly bilateral in young children)</p></list-item><list-item><p>pulsating quality</p></list-item><list-item><p>moderate or severe pain intensity</p></list-item><list-item><p>aggravation by or causing avoidance of routine physical activity</p></list-item></list></p></list-item><list-item><label>D.</label><p>During headache at least one of the following:<list list-type="order"><list-item><p>nausea and/or vomiting</p></list-item><list-item><p>photophobia and phonophobia</p></list-item></list></p></list-item><list-item><label>E.</label><p>Not attributed to another disorder</p></list-item></list></p><p><bold>Migraine with typical aura</bold><list list-type="simple"><list-item><label>A.</label><p>At least 2 attacks fulfilling criteria B-D</p></list-item><list-item><label>B.</label><p>Aura consisting of at least one of the following, but no motor weakness:<list list-type="order"><list-item><p>fully reversible visual symptoms including positive features (e.g., flickering lights, spots or lines) and/or negative features (i.e., loss of vision)</p></list-item><list-item><p>fully reversible sensory symptoms including positive features (i.e., pins and needles) and/or negative features (i.e., numbness)</p></list-item><list-item><p>fully reversible dysphasic speech disturbance</p></list-item></list></p></list-item><list-item><label>C.</label><p>At least two of the following:<list list-type="order"><list-item><p>homonymous visual symptoms and/or unilateral sensory symptoms</p></list-item><list-item><p>at least one aura symptom develops gradually over &#x02265;5 minutes and/or different aura symptoms occur in succession over &#x02265;5 minutes</p></list-item><list-item><p>each symptom lasts &#x02265;5 and &#x02264;60 minutes</p></list-item></list></p></list-item><list-item><label>D.</label><p>Headache fulfilling criteria B-D for Migraine without aura begins during the aura or follows aura within 60 minutes</p></list-item><list-item><label>E.</label><p>Not attributed to another disorder</p></list-item></list></p><p>Unlike the previous editions that were mostly based on the opinions of experts, for the latest edition there is substantial evidence available for the classification work. Already in the ICHD-II, criteria for migraine had been specifically adopted for use in children allowing a higher number of pediatric patients to be classified. The two most frequent subtypes of migraine in pediatric population are respectively migraine without aura and migraine with aura. Aura is defined as a transient focal neurological phenomenon that occurs before or during a headache. It appears gradually over several minutes and generally lasts less than 1 hour. Symptoms can be visual, sensory or motor and many children experience more than one symptom.</p><p>Migraine is the second most common cause of chronic recurrent headache in school children, with a prevalence ranging from 3.2 to 14.5% [<xref ref-type="bibr" rid="CR13">13</xref>]. However, epidemiologic studies using ICHD-II demonstrated that in 27-35% of children it was not possible to perform a specific primary headache diagnosis [<xref ref-type="bibr" rid="CR14">14</xref>-<xref ref-type="bibr" rid="CR16">16</xref>]. Criteria for migraine diagnosis in children and adolescents are confirmed in ICHD-III beta except for duration of attacks. For the ICHD-II classification migraine may last as little as 1 hour whereas in the new classification, attacks may last from 2 to 72 hours (instead of a minimum of 4 hours in adults): the evidence for untreated migraine with a duration inferior than 2 hours in children has not been substantiated.</p><p>The younger the child is, the more atypical the symptoms are. Migraine in preschool children may lack throbbing characteristics, unilaterality and full-blown autonomic symptoms [<xref ref-type="bibr" rid="CR9">9</xref>] but its paroxysmal and periodic occurrence is observed as the outstanding feature in all migraine manifestations at this age [<xref ref-type="bibr" rid="CR17">17</xref>]. Children often experience a bilateral pain, usually in frontal or temporal regions, poorly defined and invariably accompanied by pallor, nausea and vomiting. The unilateral pain, typically referred by adults, usually emerges in late adolescence or early adult life. Occipital headache is not common in children, in which case a possible organic pathology should be suspected. Pain quality is different to that of adults because it is often reported as constrictive-oppressive and for most children it is difficult to describe a headache using words like &#x0201c;throbbing&#x0201d; or to fully verbalize symptoms such as photophobia and phonophobia that must be inferred from behaviour [<xref ref-type="bibr" rid="CR18">18</xref>]. Cranial autonomic symptoms, mainly ocular and nasal (lacrimation, conjunctival injection, nasal congestion, rhinorrhoea), are frequently found in pediatric migraine, often leading to a misdiagnosis of sinus headache and delaying appropriate migraine therapy [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p>In children, migraine with aura is less frequent than migraine without aura. The most common aura symptoms in children are visual and sensorial disorders. Visual aura is typically referred as a &#x0201c;fortification spectrum&#x0201d; characterized by zigzag lines close to the fixation point that then gradually expand assuming the appearance of a convex shape displaced laterally and twinkling. Vision becomes increasingly blurred and children can experience transient hemianopsia or a complete transient unilateral blindness (<italic>amaurosis fugax</italic>). Sensorial aura is often characterized by unilateral paresthesia, hemiparesis and dysphasia. Children typically describe many small pinpricks that slowly move from the place of origin to wider regions as the arm, the leg or the face.</p><p>During the last two decades, modifications of ICHD criteria permitted to improve sensitivity of migraine diagnosis in children up to 84.4% [<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref>] but studies demonstrate that there still are deficiencies in fully recognizing pediatric headache and Ballottin demonstrated that the ICHD-II criteria are poorly applicable to children below the age of 6 years [<xref ref-type="bibr" rid="CR22">22</xref>]. Further studies are needed to define the applicability of ICHD-III criteria in the pediatric population and in order to develop alternative and more specific criteria for children. A recent study conducted by De Carlo found that 34.6% of pediatric migraine patients have osmophobia and when this symptom was utilized in the diagnostic process as an additional associated symptom, there was an increase in the percentage of subjects with a migraine diagnosis [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec4"><title>Migraine pathogenetic hypothesis</title><p>Eight genes have been so far identified as being associated with common migraine (i.e. with and without aura) [<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref>]. <italic>MTDH</italic>, <italic>LRP1</italic>, <italic>PRDM16</italic>, <italic>MEF2D</italic>, <italic>ASTN2</italic>, and <italic>PHACTR1</italic> are involved in neuronal and glutamatergic pathways; <italic>TGFBR</italic> is responsible for the maintenance of vascular integrity and function whereas <italic>TRPM8</italic> is involved in pain signalling pathways [<xref ref-type="bibr" rid="CR26">26</xref>]. Many advances in the understanding of migraine pathophysiology have been possible through to the study of the rare autosominal dominant Familial hemiplegic migraine (FHM). Gene mutations in membrane ion channel transport proteins, including <italic>CACNA1A</italic> (P/Q-type voltage-gated calcium channel), <italic>ATP1A2</italic> (sodium-potassium ATPase), <italic>SCN1A</italic> (voltage-gated sodium channel), and <italic>PRRT2</italic> (proline-rich transmembrane protein 2) lead to FHM. More recently, mutations in <italic>SLC4A4</italic> [<xref ref-type="bibr" rid="CR27">27</xref>], encoding the Na<sup>+</sup>-HCO<sub>3</sub><sup>-</sup> cotransporter NBCe1, have been identified [<xref ref-type="bibr" rid="CR28">28</xref>]. Multiple conventional and advanced MRI techniques including susceptibility weighted imaging (SWI) play a key role during an Hemiplegic Migraine attack to exclude acute arterial ischemic stroke; the transient unilateral motor weakness that characterizes this rare type of migraine usually lasts for a few hours and neuroimaging abnormalities completely resolve within 24 hrs after the attack onset [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p>The real pathophysiological mechanisms of migraine are not fully understood. For decades, the throbbing pain during migraine headache was thought to originate from dilated cranial arteries: unilateral stimulation of extra cranial and intracranial arteries was in fact associated with ipsilateral head pain [<xref ref-type="bibr" rid="CR30">30</xref>]. During the past two decades the focus on this vascular hypothesis has diminished and neuronal mechanisms have been suggested as generators of migraine headache, without abnormal activation of perivascular sensory fibers [<xref ref-type="bibr" rid="CR31">31</xref>]. More recently, current molecular and functional studies, conducted using PET, intracarotid SPECT (Single-Photon Emission Computed Tomography), MRA (magnetic resonance angiography), functional MRI and TMS (Transcranial Magnetic Stimulation), allowed to formulate a complex theory in which vascular and neurologic events cooperate in the pathogenesis of migraine attacks without aura [<xref ref-type="bibr" rid="CR32">32</xref>]. Afferent innervations of intracranial blood vessels, forming the Trigemino-Vascular System (TVS), are the essential substrate for migraine pain in this intricate network [<xref ref-type="bibr" rid="CR33">33</xref>] (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Specific environmental triggers are supposed to initiate the neuronal excitation that leads to clinical manifestations in patients with a genetic vulnerability to migraine. Migraine-specific triggers, as foods containing vasoactive amines (e.g.: tyramine and phenylethylamine), hormonal fluctuation, psychological and environmental triggers as stress, worse mood [<xref ref-type="bibr" rid="CR34">34</xref>], anxiety, fatigue, sleep deprivation, light, and rapid temperature changes, induce the activation of trigeminal nerve sensory fibers, which innervate intracranial blood vessels, by dilatation of cranial blood vessels. However, Amin in a recent study conducted using MRA during spontaneous unilateral migraine attacks, demonstrates that migraine pain is not accompanied by extracranial arterial dilatation but by only slight intracranial dilatation [<xref ref-type="bibr" rid="CR35">35</xref>].<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Migraine pain generation.</bold> Migraine triggers initiate the neuronal excitation that leads to clinical manifestations in children with a genetic vulnerability to migraine. Cortical spreading depression (CSD) triggers plasma protein extravasation from cerebral blood vessels, which in turn activates trigeminal (TG) afferents within the trigemino-vascular system (TVS). Gene mutations could reduce the threshold for firing of TG neurons. Signals are transduced to the trigeminal nucleus caudalis (TNC), which receives modulatory inputs from other brainstem nuclei (BN), such as the periaqueductal gray, the locus coeruleus and the raphe. The TNC projects to rostral brain areas, where the perception of pain is generated.</p></caption><graphic xlink:href="13052_2014_92_Fig1_HTML" id="MO1"/></fig></p><p>Therefore, the initial events that lead to the activation of nociception cascade are still not entirely clear. Brainstem network activation determines the release of vasoactive peptides such as CGRP (calcitonin gene-related peptide) and substance P from trigeminal fibers, inducing vasodilation and neurogenic inflammation [<xref ref-type="bibr" rid="CR36">36</xref>]. This inflammation increases the trigeminal sensory fibers activation and perpetuates the release of vasoactive peptides (sustaining the transmission of pain impulses to the brain) over a time span of hours to days in correspondence with the duration of a typical migraine episode. The cortical spreading depression (CSD) theory is thought to explain generation of migraine attacks with aura. Transcranial magnetic stimulation and functional MRI studies have shown that at baseline, migraneurs have a state of neuronal hyperexcitability in their cerebral cortex, especially in the occipital region. This suggests that the initial phase of a migraine attack with aura is a wave of cortical spreading depression which is associated with the suppression of spontaneous EEG activity and regional oligemia. CSD begins in the occipital region and moving anteriorly, stops at the central sulcus, and then spreads ventrally to the meningeal trigeminal fibers. Once the CSD occurs, H&#x02009;+&#x02009;and K&#x02009;+&#x02009;diffuse to the pia mater and activate meningeal nociceptors (C-fibers) which release pro-inflammatory agents after TVS activation [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p>Recent studies have suggested that some types of migraine may be related to a mitochondrial dysfunction [<xref ref-type="bibr" rid="CR38">38</xref>]. Biochemical evidence supporting this relationship consists in the fact that abnormal mitochondrial function determines a high intracellular penetration of calcium, an excessive production of free radicals and a deficient oxidative phosphorylation which ultimately causes energy failure in neurons and astrocytes. These events can trigger migraine mechanisms ultimately causing CSD. Further studies are required to investigate a possible relationship between mtDNA and migraine. Current data therefore provide a complex model in which genetic factors, causing disturbances in neuronal ion channels, make a migraineur more sensitive to multiple trigger factors. The generation of migraine pain is probably a consequence of multiple pathophysiological changes in meningeal tissues, TG (Trigeminal Ganglion), trigeminal brainstem nuclei and descending inhibitory systems that are still not fully clarified and are worth further studies. The result is an activation of the brainstem which is the principal vascular tone regulating and nociceptive processing center. Activation of the brainstem also regulates the nociceptive transition to higher structures of the central nervous system (CNS), as the thalamus and the cortex [<xref ref-type="bibr" rid="CR39">39</xref>].</p></sec><sec id="Sec5"><title>Treatment of migraine</title><p>An appropriate migraine management requires filling in a diary for at least one month in order to collect more detailed information on headache characteristics and associated signs.</p><p>Migraine preventive strategies are particularly important in children, and could be beneficial in childhood episodic syndromes. Prevention of migraine attacks includes trigger management and adequate pharmacologic treatments, when needed. Frequent migraine triggers, such as physical and mental stress, school problems, irregular and unhealthy lifestyle habits [<xref ref-type="bibr" rid="CR40">40</xref>] can be removed or modified. A correct lifestyle with appropriate nutritional and sleeping habits and regular physical activity are the first steps to achieve a high quality migraine therapy. Distraction techniques, relaxation and biofeedback are also valuable tools that pediatricians must take into account in managing migraine [<xref ref-type="bibr" rid="CR41">41</xref>-<xref ref-type="bibr" rid="CR44">44</xref>].</p><p>Acute pharmacological treatment consists in using drugs only during a migraine attack. Its goal is to completely eliminate pain and related symptoms. Nonspecific analgesics like ibuprofen and acetaminophen are widely used in pediatrics in order to control pain and have been studied in randomized, double-blind, placebo-controlled trials and found to be effective also in the treatment of acute migraine attacks [<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref>]. Triptans are the specific fist-line drugs for acute migraine treatment [<xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref>]. Although nasal spray sumatriptan [<xref ref-type="bibr" rid="CR49">49</xref>-<xref ref-type="bibr" rid="CR51">51</xref>] and zolmitriptan [<xref ref-type="bibr" rid="CR52">52</xref>] have positive randomized trials in children, only almotriptan [<xref ref-type="bibr" rid="CR53">53</xref>] (in adolescents aged 12-17 years) and rizatriptan [<xref ref-type="bibr" rid="CR54">54</xref>] (for 6-17 years olds) are now FDA-approved for pediatric use. Generally ergot alkaloid dihydroergotamine [<xref ref-type="bibr" rid="CR55">55</xref>], dopamine receptor antagonists [<xref ref-type="bibr" rid="CR56">56</xref>] and opioids are not considered first-line treatment of acute migraine in children and adolescents because of their potential side-effects and, especially regarding opioids, because of their association with the development of chronic migraine and medication overuse headache [<xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref>].</p><p>Sheridan et al. [<xref ref-type="bibr" rid="CR59">59</xref>] recently described the variability in diagnostic testing and treatment of headaches in children presenting to the emergency department and found that despite evidence based clinical guidelines, a large number of children with migraine continued to receive opioids as acute treatment.</p><p>Pharmacologic preventive treatment is generally proposed when migraine attacks occur once a week or whenever the attacks are particularly long and debilitating [<xref ref-type="bibr" rid="CR60">60</xref>]. Among migraine preventives, topiramate [<xref ref-type="bibr" rid="CR61">61</xref>-<xref ref-type="bibr" rid="CR63">63</xref>], flunarizine [<xref ref-type="bibr" rid="CR64">64</xref>], amitriptyline [<xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref>] and divalproex sodium [<xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref>] have evidence of efficacy and safety supporting their use in children.</p></sec><sec id="Sec6"><title>Current state of clinical practice and diagnosis of childhood episodic syndromes</title><p>A range of symptoms and signs (such as vertigo, torticollis, visual and sensorimotor disturbances, anorexia, recurrent abdominal pain, nausea and vomiting, motion sickness, sleep and behavioural disorders) may occur in children in the absence of headache and may precede the development of typical migraine manifestations by several years [<xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref>].</p><p>Benign paroxysmal torticollis, benign paroxysmal vertigo, cyclic vomiting syndrome and abdominal migraine are defined as &#x0201c;episodic syndromes that may be associated with migraine&#x0201d; in ICHD-III beta [<xref ref-type="bibr" rid="CR12">12</xref>]. In 2001, Jan documented a relationship between infantile colic and migraine [<xref ref-type="bibr" rid="CR71">71</xref>]. His data suggested that children with migraine were more likely to have a personal history of infantile colic and a family history of infantile colic or migraine in any of the first-degree relatives. Children with a history of infantile colic were also more likely to have a positive family history for migraine. Jan supposed that pain and crying in some genetically predisposed infants could represent a form of infantile migraine with an age specific expression. We recently confirmed the association between migraine and infantile colic with a multicenter case-control study [<xref ref-type="bibr" rid="CR72">72</xref>], suggesting that colic may represent one of the earliest clinical manifestations of migraine such as the episodic syndromes included in ICHD-III beta [<xref ref-type="bibr" rid="CR18">18</xref>] (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Paroxysmal tonic up gaze [<xref ref-type="bibr" rid="CR73">73</xref>], recurrent abdominal pain [<xref ref-type="bibr" rid="CR74">74</xref>], motion sickness [<xref ref-type="bibr" rid="CR75">75</xref>], recurrent limb pain [<xref ref-type="bibr" rid="CR76">76</xref>], and parasomnias [<xref ref-type="bibr" rid="CR77">77</xref>] are not clearly associated with migraine and are not yet universally accepted as precursors of migraine.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Age-related expression of childhood episodic syndromes common precursors of migraine.</bold> *&#x02009;=&#x02009;infantile colic is actually considered as an episodic syndrome that may be associated with migraine.</p></caption><graphic xlink:href="13052_2014_92_Fig2_HTML" id="MO2"/></fig></p><p>Childhood episodic syndromes are characterized by reversible and stereotyped attacks, with a periodic occurrence. Children are healthy and neurologically normal between attacks [<xref ref-type="bibr" rid="CR78">78</xref>-<xref ref-type="bibr" rid="CR80">80</xref>]. There are strong similarities between children with episodic syndromes and children with migraine, regarding social and demographic factors, precipitating and relieving factors, and accompanying gastrointestinal, neurologic, and vasomotor features [<xref ref-type="bibr" rid="CR17">17</xref>]. Children with episodic syndromes often have a positive family history for migraine and those with earlier-onset episodic syndromes may eventually develop migraine in adolescence or adult age [<xref ref-type="bibr" rid="CR81">81</xref>]. The clinical improvement observed with migraine-specific drugs (triptans) further confirms the association of episodic syndromes with migraine. Diagnosis of childhood episodic syndrome is one of exclusion and involves a careful anamnesis, physical examination and appropriate neurodiagnostic studies to exclude other discernable causes as epilepsy, metabolic disorders, ischemic events or psychological disorders.</p><sec id="Sec7"><title>Infant colic</title><p>Recent research suggests that infantile colic may be a childhood episodic syndrome [<xref ref-type="bibr" rid="CR72">72</xref>,<xref ref-type="bibr" rid="CR80">80</xref>]. Infantile colic affects 5-19% of babies during their first months of life and, according to Wessel criteria, it is characterized by inconsolable crying and fussing for more than 3 hours per day, more than 3 days per week and for more than 3 weeks in an otherwise healthy and well-fed infant [<xref ref-type="bibr" rid="CR82">82</xref>-<xref ref-type="bibr" rid="CR84">84</xref>].</p></sec><sec id="Sec8"><title>Benign paroxysmal torticollis of infancy (ICHD III beta 1.6.3)</title><p>Benign paroxysmal torticollis is a rare paroxismal dyskinesia that appears commonly around the age of 2 to 8 months. It is characterized by recurrent and stereotyped attacks of abnormal inclination or rotation of the head, occasionally accompanied by vomiting and ataxia. Torticollis is secondary to cervical dystonia although it may occur in association with other dystonic features such as truncal and pelvic asymmetrical posturing [<xref ref-type="bibr" rid="CR78">78</xref>]. During an episode it is possible to observe pallor, photophobia, ataxia, drowsiness and headache which resemble migraine features. The episodes often last from several hours to days, and have a spontaneous resolution. Typically, the attacks frequency and duration decline as the child grows older with a definitive resolution at the age of 5 years [<xref ref-type="bibr" rid="CR85">85</xref>].</p></sec><sec id="Sec9"><title>Benign paroxysmal vertigo of childhood (ICHD III beta 1.6.2)</title><p>Benign paroxysmal vertigo occurs as a sudden attack of unexplained fright accompanied by balance troubles or even falls [<xref ref-type="bibr" rid="CR86">86</xref>]. The onset is characterized by a sudden expression of anxiety and fear followed by attempting to grasp a person or any other support standing nearby. Autonomic signs such as dizziness, nausea, pallor, perspiration, photophobia and phonophobia may accompany vertigo. Vomiting and nystagmus are common. The episodes, lasting generally less than 5 minutes, are never associated with loss of consciousness [<xref ref-type="bibr" rid="CR87">87</xref>]. The onset is between the age of 2 to 4 years and the frequency of attacks varies from once a day to once every 1-3 months [<xref ref-type="bibr" rid="CR88">88</xref>]. Typically, children suffering from benign paroxysmal vertigo have a positive family history for migraine and a positive family and personal history for motion sickness. Some patients may develop other childhood episodic syndromes such as cyclic vomiting or recurrent abdominal pain [<xref ref-type="bibr" rid="CR89">89</xref>]. Some authors suggest that benign paroxysmal vertigo may constitute an early-onset variant of basilar-type migraine [<xref ref-type="bibr" rid="CR90">90</xref>].</p></sec><sec id="Sec10"><title>Cyclic vomiting syndrome (ICHD III beta 1.6.1.1)</title><p>This syndrome is characterized by recurrent and self-limited episodes of severe nausea and vomiting, interspersed with symptom-free periods. Affected children usually experience a stereotypical pattern of events in which a prodromal phase is followed by an emetic and a recovery phase [<xref ref-type="bibr" rid="CR91">91</xref>]. During the prodromal phase, lasting about 1.5 hours, children experience an impending episode characterized by worsening nausea and a dramatic autonomic dysfunction with decreased muscle tone, pallor, lethargy and apathy. This clinical picture evolves into emetic phase in which vomiting is typically intense, often bilious, and accompanied by persistent nausea, anorexia, retching, increased salivation, abdominal pain, headache, pallor, photophobia and phonophobia. This phase lasts an average of 24 hours before the beginning of the recovery phase characterized by remission of nausea and resumption of normal appetite, of oral intake and of a baseline clinical status [<xref ref-type="bibr" rid="CR92">92</xref>].</p><p>The onset of cyclic vomiting syndrome occurs generally before the age of 6 years and the frequency of episodes varies between 3 and 12 per year [<xref ref-type="bibr" rid="CR93">93</xref>]. The median age for resolution of vomiting episodes is 10 years and 75% of affected children will develop migraine by the age of 18 years [<xref ref-type="bibr" rid="CR94">94</xref>].</p></sec><sec id="Sec11"><title>Abdominal migraine (ICHD III beta 1.6.1.2)</title><p>Abdominal migraine is characterized by recurrent, acute-onset abdominal pain lasting for hours or days and accompanied by dysautonomic signs such as pallor, dark shadows under the eyes, flushing, anorexia and vomiting [<xref ref-type="bibr" rid="CR95">95</xref>]. Affected children experience a dull or colicky pain generally localized in periumbelical region. During the inter-episodic period children are completely healthy [<xref ref-type="bibr" rid="CR96">96</xref>]. The onset of abdominal migraine occurs at the age of 7 years with a peak of prevalence at 10 years of age [<xref ref-type="bibr" rid="CR97">97</xref>]. Some studies suggest that abdominal migraine could persist into adult life and 70% of affected children develop migraine as they grow older. There are similarities between affected children and children with migraine regarding demographic, social, clinical and familial features. Moreover, children with abdominal migraine manifest similar triggering events such as psychological stress, physical exhaustion and motion sickness [<xref ref-type="bibr" rid="CR93">93</xref>]. Sometimes, a preceding aura occurs with visual disturbance, flashing lights, numbness or a tingling sensation, slurred speech or muscle weakness.</p></sec></sec><sec id="Sec12"><title>Childhood episodic syndromes pathogenetic hypothesis</title><p>The expanding knowledge on migraine genetics and pathophysiology may be applicable to childhood episodic syndromes. According to the fact that both gut and nervous system are derived from the same embryologic tissues and that the enteric nervous system and the CNS exert direct effects on each other [<xref ref-type="bibr" rid="CR98">98</xref>], it has been hypothesized that pathogenesis of abdominal migraine consists in an increased arousal in the CNS in response to triggers, thus releasing neuropeptides and neurotrasmitters that lead to dysregulation of the gastrointestinal system. This could also explain the recent demonstrated association between infantile colic and migraine. We supposed that infants with colic experience a sensitization of the perivascular nerve terminals in the gut, as happens in the brain during a migraine attack [<xref ref-type="bibr" rid="CR72">72</xref>]. The potential role of molecules as CGRP, involved in modulation of sensory activity in both the brain and the gut, remains to be elucidated [<xref ref-type="bibr" rid="CR99">99</xref>]. A disrupted sleep pattern might be a trigger for colic symptoms, as it is often observed in patients with migraine [<xref ref-type="bibr" rid="CR100">100</xref>]. Cyclic vomiting syndrome is also believed to be a brain-gut disorder involving neuroendocrine pathways in genetically predisposed individuals [<xref ref-type="bibr" rid="CR101">101</xref>,<xref ref-type="bibr" rid="CR102">102</xref>]. The same dysregulated pathways may be involved in symptoms accompanying migraine attacks as nausea and vomiting [<xref ref-type="bibr" rid="CR103">103</xref>].</p><p>Mutations in the CACNA1A and PRRT2 genes, which are associated with FHM, have been found in some patients with benign paroxysmal torticollis and benign paroxysmal vertigo [<xref ref-type="bibr" rid="CR85">85</xref>,<xref ref-type="bibr" rid="CR104">104</xref>], thus confirming their link to migraine. Transitory vascular disturbances in cerebellar cortex, where CACNA1A is abundantly expressed, were demonstrated in temporal cortex and the vestibular nuclei respectively during episodes of torticollis and vertigo [<xref ref-type="bibr" rid="CR105">105</xref>].</p></sec><sec id="Sec13"><title>Treatment of episodic syndromes</title><p>No specific treatment exists for infant colic. Positive results have been obtained by decreasing the infant&#x02019;s level of stimulation during acute episodes [<xref ref-type="bibr" rid="CR106">106</xref>,<xref ref-type="bibr" rid="CR67">67</xref>] as it is observed in migraine. There are no known effective treatments for both benign paroxysmal torticollis and vertigo. Antiemetics could be considered in the acute phase if there is significant vomiting. Acute treatment of cyclic vomiting syndrome typically consists in rehydration and antiemetics [<xref ref-type="bibr" rid="CR18">18</xref>]. A favourable response to subcutaneous and nasal spray sumatriptan has been reported [<xref ref-type="bibr" rid="CR68">68</xref>] and represents another argument in favour of a relationship with migraine. Abdominal migraine generally responds to triptans [<xref ref-type="bibr" rid="CR106">106</xref>]. Preventive treatment with flunarizine can be considered if attacks are frequent or long-lasting [<xref ref-type="bibr" rid="CR107">107</xref>].</p></sec><sec id="Sec14"><title>Remaining concerns and future directions for migraine and related syndromes</title><p>ICHD criteria are useful to simplify and standardize diagnostic approach to primary headache, and represent the gold standard for diagnosing migraine and childhood episodic syndromes. However, applying diagnostic criteria to children can be difficult because the course of the disease and the description of the acute events are often inaccurate, especially regarding parameters like duration, intensity and localization [<xref ref-type="bibr" rid="CR108">108</xref>]. The ICHD-II criteria (and probably the new ICHD-III beta criteria too) are still poorly applicable to children under the age of 6 years [<xref ref-type="bibr" rid="CR22">22</xref>] and it is likely that infantile colic and osmophobia will be considered respectively as a precursor and an alternative symptom of migraine in future revisions, because of the strong association observed. Modification of the criteria in order to include bilateral headache, shorter duration of the attacks, nausea and/or vomiting associated with at least two out of five other associated symptoms (photophobia, phonophobia, difficulty in thinking, light-headedness or fatigue) which must be derived form behavior, in addition to the usual description of moderate to severe pain of a throbbing or pulsating nature, worsening or limiting physical activity, improved accuracy of migraine diagnosis in children [<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR22">22</xref>]. Indeed, when migraine is under-diagnosed the risk is of an immoderate use of analgesics: it is demonstrated that 42.5% of subjects with headache use medicines. 68.2% of these reported that medicines for headache were always available at home, and 22.2% were allowed to use these without asking for permission [<xref ref-type="bibr" rid="CR109">109</xref>]. Since drug overuse makes treatment of headache difficult to deal, it is important to supervise this condition, which is particularly common in adolescents [<xref ref-type="bibr" rid="CR110">110</xref>].</p><p>Significant progresses in molecular genetics have advanced our understanding of the genetic basis of migraine and related syndromes, also revealing promising treatment targets for future drug development. Genetic findings have revealed ion channels and transporter mutations as causative of migraine [<xref ref-type="bibr" rid="CR111">111</xref>], which seems to be related to ionic disturbances with a resultant altered excitability of certain areas of the brain and an age-specific phenotype.</p><p>New technological strategies such as next-generation sequencing, may aid in the identification of FHM related genes and promote the research for the missing heritability of common migraine [<xref ref-type="bibr" rid="CR112">112</xref>]. These platforms are able to generate more sequence data; they are less expensive and could help us in finding answers to how migraine attacks start [<xref ref-type="bibr" rid="CR113">113</xref>] and what the links with childhood episodic syndromes are. It is likely that the study of epigenetic mechanisms (i.e. DNA methylation and post-translational modifications of histone proteins), which affect gene expression and cellular responses to environmental signals, may explain in the next future how non-genetic triggers may modulate attack frequency of migraine [<xref ref-type="bibr" rid="CR114">114</xref>]. It is realistic to imagine that further studies may reveal tractable drug targets, and this will also help in the understanding of migraine pathogenic process, which is essential for a rational development of effective treatments.</p><p>Development of primary headache may be furthered by environmental conditions [<xref ref-type="bibr" rid="CR115">115</xref>-<xref ref-type="bibr" rid="CR117">117</xref>]. A child&#x02019;s environment includes home, school, and community and all of these areas may have profound influences on headache [<xref ref-type="bibr" rid="CR118">118</xref>]. An association between migraine, parental-reported emotional problems and self-reported anxiety suggests that emotional factors may be early contributors in the pathogenesis of pediatric headache [<xref ref-type="bibr" rid="CR119">119</xref>,<xref ref-type="bibr" rid="CR120">120</xref>].</p><p>Children with frequents attacks of paroxysmal vertigo or paroxysmal torticollis are very limited in daytime activities and this also influences familial organisation. The same is true for cyclic vomiting attacks, during which children are often hospitalized for intravenous rehydration, and for abdominal migraine, which attacks are often debilitating and can last for days. When migraine attacks are too frequent, too long, or too painful, children&#x02019;s quality of life can be affected. Therefore, it could be useful to assess the level of life quality by validated scores [<xref ref-type="bibr" rid="CR121">121</xref>], not only in migraine but also in episodic syndromes, when possible. Performing a score during the initial diagnostic assessment can also help in monitoring the therapeutic response: changes in score are an index of the adequacy of undertaken treatment. Several studies have helped to define the relationship between psychiatric and psychological co morbidities in children suffering from migraine and cyclic vomiting. Whether these comorbidities are triggers or the consequence of a chronic invalidating condition should be proven further.</p></sec></sec><sec id="Sec15" sec-type="conclusion"><title>Conclusions</title><p>Pediatricians are frequently involved in the care of children and adolescents with headache.</p><p>Diagnosing pediatric migraine may be difficult because of children&#x02019;s language and cognitive abilities and it is frequently necessary to detect migrainous symptoms from behaviour. The risk of underestimating the real prevalence of migraine in pediatric age is high and an adequate diagnosis is important to limit uncomfortable situations in school, social and family settings, to maintain a good quality of life and to avoid inappropriate therapy.</p><p>Migraine phenotype differs somewhat in the developing brain, and childhood episodic syndromes may arise before typical migraine headache. Being familiar with the characteristics and evolution of childhood episodic syndromes may help pediatricians make correct diagnosis and give adequate treatments, avoiding unnecessary investigations.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CGRP</term><def><p>Calcitonin-gene-related peptide</p></def></def-item><def-item><term>CNS</term><def><p>Central nervous system</p></def></def-item><def-item><term>CSD</term><def><p>Cortical spreading depression</p></def></def-item><def-item><term>EEG</term><def><p>Electroencephalogram</p></def></def-item><def-item><term>FDA</term><def><p>Food and Drugs Administration</p></def></def-item><def-item><term>FHM</term><def><p>Familial hemiplegic migraine</p></def></def-item><def-item><term>ICHD</term><def><p>Criteria of the International Classification of Headache Disorders</p></def></def-item><def-item><term>MRI</term><def><p>Magnetic resonance imaging</p></def></def-item><def-item><term>PET</term><def><p>Positron emission tomography</p></def></def-item><def-item><term>SPECT</term><def><p>Single-photon emission computed tomography</p></def></def-item><def-item><term>MRA</term><def><p>Magnetic resonance angiography</p></def></def-item><def-item><term>TG</term><def><p>Trigeminal Ganglion</p></def></def-item><def-item><term>TMS</term><def><p>Transcranial magnetic stimulation</p></def></def-item><def-item><term>TVS</term><def><p>Trigemino-vascular system</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>All authors declare: no support from any organisation for the submitted work, no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>All co-authors have seen and agree with the contents of the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Financial disclosure</title><p>The authors have no financial relationships relevant to this article to disclose.</p><p>The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future), to 1) publish, reproduce, distribute, display and store the Contribution, 2) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution, 3) create any other derivative work(s) based on the Contribution, 4) to exploit all subsidiary rights in the Contribution, 5) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, 6) licence any third party to do any or all of the above&#x0201d;.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>A</given-names></name><name><surname>Brennan</surname><given-names>L</given-names></name><name><surname>Abrahams</surname><given-names>M</given-names></name><name><surname>Gilder</surname><given-names>F</given-names></name></person-group><article-title>Chronic pain in children in the UK: a survey of pain clinicians and general practitioners</article-title><source>Pediatr Anaesth</source><year>2008</year><volume>18</volume><fpage>957</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9592.2008.02710.x</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>ML</given-names></name><name><surname>Shinnar</surname><given-names>S</given-names></name></person-group><article-title>Headaches in children younger than 7 years of age</article-title><source>Arch Neurol</source><year>1992</year><volume>49</volume><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1001/archneur.1992.00530250083020</pub-id><?supplied-pmid 1728267?><pub-id pub-id-type="pmid">1728267</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname><given-names>CB</given-names></name><name><surname>Kossoff</surname><given-names>EH</given-names></name></person-group><article-title>Migraine and Epilepsy in the Pediatric Population</article-title><source>Current Pain Headache Rep</source><year>2014</year><volume>18</volume><fpage>402</fpage><pub-id pub-id-type="doi">10.1007/s11916-013-0402-3</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>AD</given-names></name></person-group><article-title>Pediatric headache: update on recent research</article-title><source>Headache</source><year>2012</year><volume>52</volume><fpage>327</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.02085.x</pub-id><?supplied-pmid 22288386?><pub-id pub-id-type="pmid">22288386</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>MB</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>Increased familial risk and evidence of genetic factor in migraine</article-title><source>BMJ</source><year>1995</year><volume>311</volume><fpage>541</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1136/bmj.311.7004.541</pub-id><?supplied-pmid 7663209?><pub-id pub-id-type="pmid">7663209</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bener</surname><given-names>A</given-names></name><name><surname>Uduman</surname><given-names>SA</given-names></name><name><surname>Qassimi</surname><given-names>EM</given-names></name><name><surname>Khalaily</surname><given-names>G</given-names></name><name><surname>Sztriha</surname><given-names>L</given-names></name><name><surname>Kilpelainen</surname><given-names>H</given-names></name><name><surname>Obineche</surname><given-names>E</given-names></name></person-group><article-title>Genetic and environmental factors associated with migraine in schoolchildren</article-title><source>Headache</source><year>2000</year><volume>40</volume><fpage>152</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2000.00021.x</pub-id><?supplied-pmid 10759915?><pub-id pub-id-type="pmid">10759915</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>V</given-names></name><name><surname>Gervil</surname><given-names>M</given-names></name><name><surname>Kyvik</surname><given-names>KO</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>MB</given-names></name></person-group><article-title>Evidence of a genetic factor in migraine with aura: a population-based Danish twin study</article-title><source>Ann Neurol</source><year>1999</year><volume>45</volume><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1002/1531-8249(199902)45:2&#x0003c;242::AID-ANA15&#x0003e;3.0.CO;2-1</pub-id><?supplied-pmid 9989627?><pub-id pub-id-type="pmid">9989627</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>P</given-names></name><name><surname>Di Lorenzo</surname><given-names>G</given-names></name><name><surname>Malpezzi</surname><given-names>MG</given-names></name><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Cesarino</surname><given-names>F</given-names></name><name><surname>Faroni</surname><given-names>J</given-names></name><name><surname>Siracusano</surname><given-names>A</given-names></name><name><surname>Troisi</surname><given-names>A</given-names></name></person-group><article-title>Depressive symptoms and insecure attachment as predictors of disability in a clinical population of patients with episodic and chronic migraine</article-title><source>Headache</source><year>2005</year><volume>45</volume><fpage>561</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2005.05110.x</pub-id><?supplied-pmid 15953275?><pub-id pub-id-type="pmid">15953275</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>H</given-names></name><name><surname>Gladstein</surname><given-names>J</given-names></name></person-group><article-title>Pediatric headache: a clinical review</article-title><source>Headache</source><year>2012</year><volume>52</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.02086.x</pub-id><?supplied-pmid 22288433?><pub-id pub-id-type="pmid">22288433</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arruda</surname><given-names>MA</given-names></name><name><surname>Bigal</surname><given-names>ME</given-names></name></person-group><article-title>Migraine and migraine subtypes in preadolescent children: association with school performance</article-title><source>Neurology</source><year>2012</year><volume>79</volume><fpage>1881</fpage><lpage>1888</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e318271f812</pub-id><?supplied-pmid 23109652?><pub-id pub-id-type="pmid">23109652</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The International Headache Society</collab></person-group><article-title>The International Classification of Headache Disorders: 2nd edition</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><issue>Suppl 1</issue><fpage>9</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">14979299</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The International Headache Society</collab></person-group><article-title>The International Classification of Headache Disorders, 3rd edition (beta version)</article-title><source>Cephalalgia</source><year>2013</year><volume>33</volume><fpage>629</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">23771276</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozge</surname><given-names>A</given-names></name><name><surname>Termine</surname><given-names>C</given-names></name><name><surname>Antonaci</surname><given-names>F</given-names></name><name><surname>Natriashvili</surname><given-names>S</given-names></name><name><surname>Guidetti</surname><given-names>V</given-names></name><name><surname>Wober-Bingol</surname><given-names>C</given-names></name></person-group><article-title>Overview of diagnosis and management of pediatric headache. Part I: diagnosis</article-title><source>J Headache Pain</source><year>2011</year><volume>12</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s10194-011-0297-5</pub-id><?supplied-pmid 21359874?><pub-id pub-id-type="pmid">21359874</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroner-Herwig</surname><given-names>B</given-names></name><name><surname>Heinrich</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>L</given-names></name></person-group><article-title>Headache in German children and adolescents: a population-based epidemiological study</article-title><source>Cephalalgia</source><year>2007</year><volume>27</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2007.01319.x</pub-id><?supplied-pmid 17598791?><pub-id pub-id-type="pmid">17598791</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>L</given-names></name><name><surname>Kroner-Herwig</surname><given-names>B</given-names></name></person-group><article-title>Self-report of headache in children and adolescents in Germany: possibilities and confines of questionnaire data for headache classification</article-title><source>Cephalalgia</source><year>2009</year><volume>29</volume><fpage>864</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01812.x</pub-id><?supplied-pmid 19250286?><pub-id pub-id-type="pmid">19250286</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassmann</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>L</given-names></name><name><surname>Heinrich</surname><given-names>M</given-names></name><name><surname>Kroner-Herwig</surname><given-names>B</given-names></name></person-group><article-title>One-year course of pediatric headache in children and adolescents aged 8-15 years</article-title><source>Cephalalgia</source><year>2008</year><volume>28</volume><fpage>1154</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01657.x</pub-id><?supplied-pmid 18727649?><pub-id pub-id-type="pmid">18727649</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuvellier</surname><given-names>JC</given-names></name><name><surname>Lepine</surname><given-names>A</given-names></name></person-group><article-title>Childhood periodic syndromes</article-title><source>Pediatr Neurol</source><year>2010</year><volume>42</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2009.07.001</pub-id><?supplied-pmid 20004856?><pub-id pub-id-type="pmid">20004856</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelfand</surname><given-names>AA</given-names></name></person-group><article-title>Migraine and childhood periodic syndromes in children and adolescents</article-title><source>Curr Opin Neurol</source><year>2013</year><volume>26</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1097/WCO.0b013e32836085c7</pub-id><?supplied-pmid 23549418?><pub-id pub-id-type="pmid">23549418</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelfand</surname><given-names>AA</given-names></name><name><surname>Reider</surname><given-names>AC</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Cranial autonomic symptoms in pediatric migraine are the rule, not the exception</article-title><source>Neurology</source><year>2013</year><volume>81</volume><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31829d872a</pub-id><?supplied-pmid 23897870?><pub-id pub-id-type="pmid">23897870</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wober-Bingol</surname><given-names>C</given-names></name><name><surname>Wober</surname><given-names>C</given-names></name><name><surname>Karwautz</surname><given-names>A</given-names></name><name><surname>Auterith</surname><given-names>A</given-names></name><name><surname>Serim</surname><given-names>M</given-names></name><name><surname>Zebenholzer</surname><given-names>K</given-names></name><name><surname>Aydinkoc</surname><given-names>K</given-names></name><name><surname>Kienbacher</surname><given-names>C</given-names></name><name><surname>Wanner</surname><given-names>C</given-names></name><name><surname>Wessely</surname><given-names>P</given-names></name></person-group><article-title>Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><fpage>12</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2004.00621.x</pub-id><?supplied-pmid 14687007?><pub-id pub-id-type="pmid">14687007</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Winner</surname><given-names>P</given-names></name><name><surname>Kabbouche</surname><given-names>MA</given-names></name><name><surname>Gladstein</surname><given-names>J</given-names></name><name><surname>Yonker</surname><given-names>M</given-names></name><name><surname>Lewis</surname><given-names>D</given-names></name><name><surname>Pearlman</surname><given-names>E</given-names></name><name><surname>Linder</surname><given-names>SL</given-names></name><name><surname>Rothner</surname><given-names>AD</given-names></name><name><surname>Powers</surname><given-names>SW</given-names></name></person-group><article-title>Use of the ICHD-II criteria in the diagnosis of pediatric migraine</article-title><source>Headache</source><year>2005</year><volume>45</volume><fpage>1288</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2005.00260.x</pub-id><?supplied-pmid 16324160?><pub-id pub-id-type="pmid">16324160</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balottin</surname><given-names>U</given-names></name><name><surname>Termine</surname><given-names>C</given-names></name><name><surname>Nicoli</surname><given-names>F</given-names></name><name><surname>Quadrelli</surname><given-names>M</given-names></name><name><surname>Ferrari-Ginevra</surname><given-names>O</given-names></name><name><surname>Lanzi</surname><given-names>G</given-names></name></person-group><article-title>Idiopathic headache in children under six years of age: a follow-up study</article-title><source>Headache</source><year>2005</year><volume>45</volume><fpage>705</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2005.05138a.x</pub-id><?supplied-pmid 15953303?><pub-id pub-id-type="pmid">15953303</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Carlo</surname><given-names>D</given-names></name><name><surname>Dal Zotto</surname><given-names>L</given-names></name><name><surname>Perissinotto</surname><given-names>E</given-names></name><name><surname>Gallo</surname><given-names>L</given-names></name><name><surname>Gatta</surname><given-names>M</given-names></name><name><surname>Balottin</surname><given-names>U</given-names></name><name><surname>Mazzotta</surname><given-names>G</given-names></name><name><surname>Moscato</surname><given-names>D</given-names></name><name><surname>Raieli</surname><given-names>V</given-names></name><name><surname>Rossi</surname><given-names>LN</given-names></name><name><surname>Sangermani</surname><given-names>R</given-names></name><name><surname>Soriani</surname><given-names>S</given-names></name><name><surname>Termine</surname><given-names>C</given-names></name><name><surname>Tozzi</surname><given-names>E</given-names></name><name><surname>Vecchio</surname><given-names>A</given-names></name><name><surname>Zanchin</surname><given-names>G</given-names></name><name><surname>Battistella</surname><given-names>PA</given-names></name></person-group><article-title>Osmophobia in migraine classification: a multicentre study in juvenile patients</article-title><source>Cephalalgia</source><year>2010</year><volume>30</volume><fpage>1486</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1177/0333102410362928</pub-id><?supplied-pmid 20974611?><pub-id pub-id-type="pmid">20974611</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Kallela</surname><given-names>M</given-names></name><name><surname>Todt</surname><given-names>U</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Calafato</surname><given-names>MS</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Dimas</surname><given-names>AS</given-names></name><name><surname>Freilinger</surname><given-names>T</given-names></name><name><surname>M&#x000fc;ller-Myhsok</surname><given-names>B</given-names></name><name><surname>Artto</surname><given-names>V</given-names></name><name><surname>Inouye</surname><given-names>M</given-names></name><name><surname>Alakurtti</surname><given-names>K</given-names></name><name><surname>Kaunisto</surname><given-names>MA</given-names></name><name><surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname><given-names>E</given-names></name><name><surname>de Vries</surname><given-names>B</given-names></name><name><surname>Stam</surname><given-names>AH</given-names></name><name><surname>Weller</surname><given-names>CM</given-names></name><name><surname>Heinze</surname><given-names>A</given-names></name><name><surname>Heinze-Kuhn</surname><given-names>K</given-names></name><name><surname>Goebel</surname><given-names>I</given-names></name><name><surname>Borck</surname><given-names>G</given-names></name><name><surname>G&#x000f6;bel</surname><given-names>H</given-names></name><name><surname>Steinberg</surname><given-names>S</given-names></name><name><surname>Wolf</surname><given-names>C</given-names></name><name><surname>Bj&#x000f6;rnsson</surname><given-names>A</given-names></name><name><surname>Gudmundsson</surname><given-names>G</given-names></name><name><surname>Kirchmann</surname><given-names>M</given-names></name><name><surname>Hauge</surname><given-names>A</given-names></name><name><surname>Werge</surname><given-names>T</given-names></name><etal/></person-group><article-title>Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>869</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1038/ng.652</pub-id><?supplied-pmid 20802479?><pub-id pub-id-type="pmid">20802479</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Schurks</surname><given-names>M</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>De Vries</surname><given-names>B</given-names></name><name><surname>Schminke</surname><given-names>U</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name><name><surname>Fendrich</surname><given-names>K</given-names></name><name><surname>Volzke</surname><given-names>H</given-names></name><name><surname>Ernst</surname><given-names>F</given-names></name><name><surname>Griffiths</surname><given-names>LR</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Kallela</surname><given-names>M</given-names></name><name><surname>Freilinger</surname><given-names>T</given-names></name><name><surname>Kubisch</surname><given-names>C</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>Hoffmann</surname><given-names>W</given-names></name><name><surname>Zee</surname><given-names>RY</given-names></name><name><surname>Kurth</surname><given-names>T</given-names></name></person-group><article-title>Genome-wide association study reveals three susceptibility loci for common migraine in the general population</article-title><source>Nat Genet</source><year>2011</year><volume>43</volume><fpage>695</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1038/ng.856</pub-id><?supplied-pmid 21666692?><pub-id pub-id-type="pmid">21666692</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>MD</given-names></name></person-group><article-title>Headache: the changing migraine brain</article-title><source>Lancet Neurol</source><year>2013</year><volume>12</volume><fpage>6</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(12)70290-9</pub-id><?supplied-pmid 23237889?><pub-id pub-id-type="pmid">23237889</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Van Paesschen</surname><given-names>W</given-names></name><name><surname>Stalmans</surname><given-names>I</given-names></name><name><surname>Horita</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Bergmans</surname><given-names>BA</given-names></name><name><surname>Legius</surname><given-names>E</given-names></name><name><surname>Riant</surname><given-names>F</given-names></name><name><surname>De Jonghe</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sekine</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>T</given-names></name><name><surname>Fujimoto</surname><given-names>I</given-names></name><name><surname>Mikoshiba</surname><given-names>K</given-names></name><name><surname>Shimadzu</surname><given-names>M</given-names></name><name><surname>Shiohara</surname><given-names>M</given-names></name><name><surname>Braverman</surname><given-names>N</given-names></name><name><surname>Al-Gazali</surname><given-names>L</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Seki</surname><given-names>G</given-names></name></person-group><article-title>Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>15963</fpage><lpage>15968</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008705107</pub-id><?supplied-pmid 20798035?><pub-id pub-id-type="pmid">20798035</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecchia</surname><given-names>D</given-names></name><name><surname>Pietrobon</surname><given-names>D</given-names></name></person-group><article-title>Migraine: a disorder of brain excitatory-inhibitory balance?</article-title><source>Trends Neurosci</source><year>2012</year><volume>35</volume><fpage>507</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2012.04.007</pub-id><?supplied-pmid 22633369?><pub-id pub-id-type="pmid">22633369</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosemani</surname><given-names>T</given-names></name><name><surname>Burton</surname><given-names>VJ</given-names></name><name><surname>Felling</surname><given-names>RJ</given-names></name><name><surname>Leigh</surname><given-names>R</given-names></name><name><surname>Oakley</surname><given-names>C</given-names></name><name><surname>Poretti</surname><given-names>A</given-names></name><name><surname>Huisman</surname><given-names>TA</given-names></name></person-group><article-title>Pediatric hemiplegic migraine: Role of multiple MRI techniques in evaluation of reversible hypoperfusion</article-title><source>Cephalalgia</source><year>2013</year><volume>34</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1177/0333102413509432</pub-id><?supplied-pmid 24142848?><pub-id pub-id-type="pmid">24142848</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tunis</surname><given-names>MM</given-names></name><name><surname>Wolff</surname><given-names>HG</given-names></name></person-group><article-title>Studies on headache; long-term observations of the reactivity of the cranial arteries in subjects with vascular headache of the migraine type</article-title><source>AMA Arch Neurol Psychiatry</source><year>1953</year><volume>70</volume><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1001/archneurpsyc.1953.02320350003001</pub-id><?supplied-pmid 13091503?><pub-id pub-id-type="pmid">13091503</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>The vascular theory of migraine&#x02013;a great story wrecked by the facts</article-title><source>Brain</source><year>2009</year><volume>132</volume><fpage>6</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1093/brain/awn321</pub-id><?supplied-pmid 19098031?><pub-id pub-id-type="pmid">19098031</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Uddman</surname><given-names>R</given-names></name></person-group><article-title>Neurobiology in primary headaches</article-title><source>Brain Res Brain Res Rev</source><year>2005</year><volume>48</volume><fpage>438</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.09.007</pub-id><?supplied-pmid 15914251?><pub-id pub-id-type="pmid">15914251</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messlinger</surname><given-names>K</given-names></name></person-group><article-title>Migraine: where and how does the pain originate?</article-title><source>Exp Brain Res</source><year>2009</year><volume>196</volume><fpage>179</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1007/s00221-009-1756-y</pub-id><?supplied-pmid 19288089?><pub-id pub-id-type="pmid">19288089</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlson</surname><given-names>CW</given-names></name><name><surname>Litzenburg</surname><given-names>CC</given-names></name><name><surname>Sampilo</surname><given-names>ML</given-names></name><name><surname>Rapoff</surname><given-names>MA</given-names></name><name><surname>Connelly</surname><given-names>M</given-names></name><name><surname>Bickel</surname><given-names>JL</given-names></name><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Powers</surname><given-names>SW</given-names></name></person-group><article-title>Relationship Between Daily Mood and Migraine in Children</article-title><source>Headache</source><year>2013</year><volume>53</volume><fpage>1624</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1111/head.12215</pub-id><?supplied-pmid 24102349?><pub-id pub-id-type="pmid">24102349</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>FM</given-names></name><name><surname>Asghar</surname><given-names>MS</given-names></name><name><surname>Hougaard</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>AE</given-names></name><name><surname>Larsen</surname><given-names>VA</given-names></name><name><surname>De Koning</surname><given-names>PJ</given-names></name><name><surname>Larsson</surname><given-names>HB</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name></person-group><article-title>Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study</article-title><source>Lancet Neurol</source><year>2013</year><volume>12</volume><fpage>454</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(13)70067-X</pub-id><?supplied-pmid 23578775?><pub-id pub-id-type="pmid">23578775</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durham</surname><given-names>PL</given-names></name></person-group><article-title>Calcitonin gene-related peptide (CGRP) and migraine</article-title><source>Headache</source><year>2006</year><volume>46</volume><issue>Suppl 1</issue><fpage>S3</fpage><lpage>S8</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00483.x</pub-id><?supplied-pmid 16927957?><pub-id pub-id-type="pmid">16927957</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayata</surname><given-names>C</given-names></name></person-group><article-title>Cortical spreading depression triggers migraine attack: pro</article-title><source>Headache</source><year>2010</year><volume>50</volume><fpage>725</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2010.01647.x</pub-id><?supplied-pmid 20456160?><pub-id pub-id-type="pmid">20456160</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yorns</surname><given-names>WR</given-names><suffix>Jr</suffix></name><name><surname>Hardison</surname><given-names>HH</given-names></name></person-group><article-title>Mitochondrial dysfunction in migraine</article-title><source>Semin Pediatr Neurol</source><year>2013</year><volume>20</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.spen.2013.09.002</pub-id><?supplied-pmid 24331360?><pub-id pub-id-type="pmid">24331360</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Ekman</surname><given-names>R</given-names></name></person-group><article-title>Vasoactive peptide release in the extracerebral circulation of humans during migraine headache</article-title><source>Ann Neurol</source><year>1990</year><volume>28</volume><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1002/ana.410280213</pub-id><?supplied-pmid 1699472?><pub-id pub-id-type="pmid">1699472</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>MJ</given-names></name><name><surname>Lehman</surname><given-names>L</given-names></name><name><surname>Slater</surname><given-names>S</given-names></name><name><surname>Kabbouche</surname><given-names>MA</given-names></name><name><surname>LeCates</surname><given-names>SL</given-names></name><name><surname>Segers</surname><given-names>A</given-names></name><name><surname>Manning</surname><given-names>P</given-names></name><name><surname>Powers</surname><given-names>SW</given-names></name><name><surname>Hershey</surname><given-names>AD</given-names></name></person-group><article-title>Menstrual migraine in adolescents</article-title><source>Headache</source><year>2009</year><volume>49</volume><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2009.01347.x</pub-id><?supplied-pmid 19220498?><pub-id pub-id-type="pmid">19220498</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blume</surname><given-names>HK</given-names></name><name><surname>Brockman</surname><given-names>LN</given-names></name><name><surname>Breuner</surname><given-names>CC</given-names></name></person-group><article-title>Biofeedback therapy for pediatric headache: factors associated with response</article-title><source>Headache</source><year>2012</year><volume>52</volume><fpage>1377</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02215.x</pub-id><?supplied-pmid 22804229?><pub-id pub-id-type="pmid">22804229</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varkey</surname><given-names>E</given-names></name><name><surname>Cider</surname><given-names>A</given-names></name><name><surname>Carlsson</surname><given-names>J</given-names></name><name><surname>Linde</surname><given-names>M</given-names></name></person-group><article-title>Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls</article-title><source>Cephalalgia</source><year>2011</year><volume>31</volume><fpage>1428</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1177/0333102411419681</pub-id><?supplied-pmid 21890526?><pub-id pub-id-type="pmid">21890526</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>RW</given-names></name></person-group><article-title>A rational approach to the management of chronic migraine</article-title><source>Headache</source><year>2013</year><volume>53</volume><fpage>168</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1111/head.12014</pub-id><?supplied-pmid 23293866?><pub-id pub-id-type="pmid">23293866</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bromberg</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>ME</given-names></name><name><surname>Black</surname><given-names>RA</given-names></name><name><surname>Surette</surname><given-names>DA</given-names></name><name><surname>Zacharoff</surname><given-names>KL</given-names></name><name><surname>Chiauzzi</surname><given-names>EJ</given-names></name></person-group><article-title>A randomized trial of a web-based intervention to improve migraine self-management and coping</article-title><source>Headache</source><year>2012</year><volume>52</volume><fpage>244</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.02031.x</pub-id><?supplied-pmid 22413151?><pub-id pub-id-type="pmid">22413151</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DW</given-names></name><name><surname>Kellstein</surname><given-names>D</given-names></name><name><surname>Dahl</surname><given-names>G</given-names></name><name><surname>Burke</surname><given-names>B</given-names></name><name><surname>Frank</surname><given-names>LM</given-names></name><name><surname>Toor</surname><given-names>S</given-names></name><name><surname>Northam</surname><given-names>RS</given-names></name><name><surname>White</surname><given-names>LW</given-names></name><name><surname>Lawson</surname><given-names>L</given-names></name></person-group><article-title>Children&#x02019;s ibuprofen suspension for the acute treatment of pediatric migraine</article-title><source>Headache</source><year>2002</year><volume>42</volume><fpage>780</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2002.02180.x</pub-id><?supplied-pmid 12390641?><pub-id pub-id-type="pmid">12390641</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamalainen</surname><given-names>ML</given-names></name><name><surname>Hoppu</surname><given-names>K</given-names></name><name><surname>Valkeila</surname><given-names>E</given-names></name><name><surname>Santavuori</surname><given-names>P</given-names></name></person-group><article-title>Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study</article-title><source>Neurology</source><year>1997</year><volume>48</volume><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1212/WNL.48.1.103</pub-id><?supplied-pmid 9008503?><pub-id pub-id-type="pmid">9008503</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahonen</surname><given-names>K</given-names></name><name><surname>Hamalainen</surname><given-names>ML</given-names></name><name><surname>Rantala</surname><given-names>H</given-names></name><name><surname>Hoppu</surname><given-names>K</given-names></name></person-group><article-title>Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>883</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1212/01.WNL.0000115105.05966.A7</pub-id><?supplied-pmid 15037686?><pub-id pub-id-type="pmid">15037686</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winner</surname><given-names>P</given-names></name><name><surname>Rothner</surname><given-names>AD</given-names></name><name><surname>Saper</surname><given-names>J</given-names></name><name><surname>Nett</surname><given-names>R</given-names></name><name><surname>Asgharnejad</surname><given-names>M</given-names></name><name><surname>Laurenza</surname><given-names>A</given-names></name><name><surname>Austin</surname><given-names>R</given-names></name><name><surname>Peykamian</surname><given-names>M</given-names></name></person-group><article-title>A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents</article-title><source>Pediatrics</source><year>2000</year><volume>106</volume><fpage>989</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1542/peds.106.5.989</pub-id><?supplied-pmid 11061765?><pub-id pub-id-type="pmid">11061765</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DW</given-names></name><name><surname>Winner</surname><given-names>P</given-names></name><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Wasiewski</surname><given-names>WW</given-names></name></person-group><article-title>Efficacy of zolmitriptan nasal spray in adolescent migraine</article-title><source>Pediatrics</source><year>2007</year><volume>120</volume><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1542/peds.2007-0085</pub-id><?supplied-pmid 17671066?><pub-id pub-id-type="pmid">17671066</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linder</surname><given-names>SL</given-names></name><name><surname>Mathew</surname><given-names>NT</given-names></name><name><surname>Cady</surname><given-names>RK</given-names></name><name><surname>Finlayson</surname><given-names>G</given-names></name><name><surname>Ishkanian</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>DW</given-names></name></person-group><article-title>Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial</article-title><source>Headache</source><year>2008</year><volume>48</volume><fpage>1326</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2008.01138.x</pub-id><?supplied-pmid 18484981?><pub-id pub-id-type="pmid">18484981</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahonen</surname><given-names>K</given-names></name><name><surname>Hamalainen</surname><given-names>ML</given-names></name><name><surname>Eerola</surname><given-names>M</given-names></name><name><surname>Hoppu</surname><given-names>K</given-names></name></person-group><article-title>A randomized trial of rizatriptan in migraine attacks in children</article-title><source>Neurology</source><year>2006</year><volume>67</volume><fpage>1135</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000238179.79888.44</pub-id><?supplied-pmid 16943370?><pub-id pub-id-type="pmid">16943370</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saper</surname><given-names>JR</given-names></name><name><surname>Silberstein</surname><given-names>S</given-names></name></person-group><article-title>Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine</article-title><source>Headache</source><year>2006</year><volume>46</volume><issue>Suppl 4</issue><fpage>S171</fpage><lpage>S181</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00601.x</pub-id><?supplied-pmid 17078849?><pub-id pub-id-type="pmid">17078849</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trottier</surname><given-names>ED</given-names></name><name><surname>Bailey</surname><given-names>B</given-names></name><name><surname>Lucas</surname><given-names>N</given-names></name><name><surname>Lortie</surname><given-names>A</given-names></name></person-group><article-title>Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia</article-title><source>Am J Emerg Med</source><year>2012</year><volume>30</volume><fpage>456</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2010.12.020</pub-id><?supplied-pmid 21296523?><pub-id pub-id-type="pmid">21296523</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Serrano</surname><given-names>D</given-names></name><name><surname>Buse</surname><given-names>D</given-names></name><name><surname>Scher</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study</article-title><source>Headache</source><year>2008</year><volume>48</volume><fpage>1157</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2008.01217.x</pub-id><?supplied-pmid 18808500?><pub-id pub-id-type="pmid">18808500</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodick</surname><given-names>D</given-names></name><name><surname>Freitag</surname><given-names>F</given-names></name></person-group><article-title>Evidence-based understanding of medication-overuse headache: clinical implications</article-title><source>Headache</source><year>2006</year><volume>46</volume><issue>Suppl 4</issue><fpage>S202</fpage><lpage>S211</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00604.x</pub-id><?supplied-pmid 17078852?><pub-id pub-id-type="pmid">17078852</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>AD</given-names></name></person-group><article-title>Current approaches to the diagnosis and management of pediatric migraine</article-title><source>Lancet Neurol</source><year>2010</year><volume>9</volume><fpage>190</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(09)70303-5</pub-id><?supplied-pmid 20129168?><pub-id pub-id-type="pmid">20129168</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshmi</surname><given-names>CV</given-names></name><name><surname>Singhi</surname><given-names>P</given-names></name><name><surname>Malhi</surname><given-names>P</given-names></name><name><surname>Ray</surname><given-names>M</given-names></name></person-group><article-title>Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial</article-title><source>J Child Neurol</source><year>2007</year><volume>22</volume><fpage>829</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1177/0883073807304201</pub-id><?supplied-pmid 17715274?><pub-id pub-id-type="pmid">17715274</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>D</given-names></name><name><surname>Winner</surname><given-names>P</given-names></name><name><surname>Saper</surname><given-names>J</given-names></name><name><surname>Ness</surname><given-names>S</given-names></name><name><surname>Polverejan</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Kurland</surname><given-names>CL</given-names></name><name><surname>Nye</surname><given-names>J</given-names></name><name><surname>Yuen</surname><given-names>E</given-names></name><name><surname>Eerdekens</surname><given-names>M</given-names></name><name><surname>Ford</surname><given-names>L</given-names></name></person-group><article-title>Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age</article-title><source>Pediatrics</source><year>2009</year><volume>123</volume><fpage>924</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1542/peds.2008-0642</pub-id><?supplied-pmid 19255022?><pub-id pub-id-type="pmid">19255022</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>DC</given-names></name><name><surname>Meckler</surname><given-names>GD</given-names></name><name><surname>Spiro</surname><given-names>DM</given-names></name><name><surname>Koch</surname><given-names>TK</given-names></name><name><surname>Hansen</surname><given-names>ML</given-names></name></person-group><article-title>Diagnostic testing and treatment of pediatric headache in the emergency department</article-title><source>J Pediatr</source><year>2013</year><volume>163</volume><fpage>1634</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2013.07.006</pub-id><?supplied-pmid 23968749?><pub-id pub-id-type="pmid">23968749</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>D</given-names></name><name><surname>Paradiso</surname><given-names>E</given-names></name></person-group><article-title>A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study</article-title><source>Headache</source><year>2007</year><volume>47</volume><fpage>1409</fpage><lpage>1417</lpage><?supplied-pmid 18052950?><pub-id pub-id-type="pmid">18052950</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorge</surname><given-names>F</given-names></name><name><surname>De Simone</surname><given-names>R</given-names></name><name><surname>Marano</surname><given-names>E</given-names></name><name><surname>Nolano</surname><given-names>M</given-names></name><name><surname>Orefice</surname><given-names>G</given-names></name><name><surname>Carrieri</surname><given-names>P</given-names></name></person-group><article-title>Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study</article-title><source>Cephalalgia</source><year>1988</year><volume>8</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1988.0801001.x</pub-id><?supplied-pmid 3282670?><pub-id pub-id-type="pmid">3282670</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Powers</surname><given-names>SW</given-names></name><name><surname>Bentti</surname><given-names>AL</given-names></name><name><surname>Degrauw</surname><given-names>TJ</given-names></name></person-group><article-title>Effectiveness of amitriptyline in the prophylactic management of childhood headaches</article-title><source>Headache</source><year>2000</year><volume>40</volume><fpage>539</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2000.00085.x</pub-id><?supplied-pmid 10940092?><pub-id pub-id-type="pmid">10940092</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DW</given-names></name><name><surname>Diamond</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>V</given-names></name></person-group><article-title>Prophylactic treatment of pediatric migraine</article-title><source>Headache</source><year>2004</year><volume>44</volume><fpage>230</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2004.04052.x</pub-id><?supplied-pmid 15012660?><pub-id pub-id-type="pmid">15012660</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apostol</surname><given-names>G</given-names></name><name><surname>Pakalnis</surname><given-names>A</given-names></name><name><surname>Laforet</surname><given-names>GA</given-names></name><name><surname>Robieson</surname><given-names>WZ</given-names></name><name><surname>Olson</surname><given-names>E</given-names></name><name><surname>Abi-Saab</surname><given-names>WM</given-names></name><name><surname>Saltarelli</surname><given-names>M</given-names></name></person-group><article-title>Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents</article-title><source>Headache</source><year>2009</year><volume>49</volume><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2008.01299.x</pub-id><?supplied-pmid 19040678?><pub-id pub-id-type="pmid">19040678</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apostol</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>DW</given-names></name><name><surname>Laforet</surname><given-names>GA</given-names></name><name><surname>Robieson</surname><given-names>WZ</given-names></name><name><surname>Fugate</surname><given-names>JM</given-names></name><name><surname>Abi-Saab</surname><given-names>WM</given-names></name><name><surname>Saltarelli</surname><given-names>MD</given-names></name></person-group><article-title>Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study</article-title><source>Headache</source><year>2009</year><volume>49</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2008.01279.x</pub-id><?supplied-pmid 19040679?><pub-id pub-id-type="pmid">19040679</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubman</surname><given-names>B</given-names></name></person-group><article-title>Clinical trial of the treatment of colic by modification of parent-infant interaction</article-title><source>Pediatrics</source><year>1984</year><volume>74</volume><fpage>998</fpage><lpage>1003</lpage><?supplied-pmid 6390331?><pub-id pub-id-type="pmid">6390331</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>S</given-names></name></person-group><article-title>Troublesome crying in infants: effect of advice to reduce stimulation</article-title><source>Arch Dis Child</source><year>1991</year><volume>66</volume><fpage>1416</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1136/adc.66.12.1416</pub-id><?supplied-pmid 1776889?><pub-id pub-id-type="pmid">1776889</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hikita</surname><given-names>T</given-names></name><name><surname>Kodama</surname><given-names>H</given-names></name><name><surname>Kaneko</surname><given-names>S</given-names></name><name><surname>Amakata</surname><given-names>K</given-names></name><name><surname>Ogita</surname><given-names>K</given-names></name><name><surname>Mochizuki</surname><given-names>D</given-names></name><name><surname>Kaga</surname><given-names>F</given-names></name><name><surname>Nakamoto</surname><given-names>N</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name></person-group><article-title>Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial</article-title><source>Cephalalgia</source><year>2011</year><volume>31</volume><fpage>504</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1177/0333102410390398</pub-id><?supplied-pmid 21147834?><pub-id pub-id-type="pmid">21147834</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortimer</surname><given-names>MJ</given-names></name><name><surname>Kay</surname><given-names>J</given-names></name><name><surname>Jaron</surname><given-names>A</given-names></name></person-group><article-title>Clinical epidemiology of childhood abdominal migraine in an urban general practice</article-title><source>Dev Med Child Neurol</source><year>1993</year><volume>35</volume><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8749.1993.tb11629.x</pub-id><?supplied-pmid 8462757?><pub-id pub-id-type="pmid">8462757</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jernigan</surname><given-names>SA</given-names></name><name><surname>Ware</surname><given-names>LM</given-names></name></person-group><article-title>Reversible quantitative EEG changes in a case of cyclic vomiting: evidence for migraine equivalent</article-title><source>Dev Med Child Neurol</source><year>1991</year><volume>33</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8749.1991.tb14787.x</pub-id><?supplied-pmid 1995411?><pub-id pub-id-type="pmid">1995411</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jan</surname><given-names>MM</given-names></name><name><surname>Al-Buhairi</surname><given-names>AR</given-names></name></person-group><article-title>Is infantile colic a migraine-related phenomenon?</article-title><source>Clin Pediatr</source><year>2001</year><volume>40</volume><fpage>295</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1177/000992280104000512</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanello</surname><given-names>S</given-names></name><name><surname>Spiri</surname><given-names>D</given-names></name><name><surname>Marcuzzi</surname><given-names>E</given-names></name><name><surname>Zanin</surname><given-names>A</given-names></name><name><surname>Boizeau</surname><given-names>P</given-names></name><name><surname>Riviere</surname><given-names>S</given-names></name><name><surname>Vizeneux</surname><given-names>A</given-names></name><name><surname>Moretti</surname><given-names>R</given-names></name><name><surname>Carbajal</surname><given-names>R</given-names></name><name><surname>Mercier</surname><given-names>JC</given-names></name><name><surname>Wood</surname><given-names>C</given-names></name><name><surname>Zuccotti</surname><given-names>GV</given-names></name><name><surname>Crichiutti</surname><given-names>G</given-names></name><name><surname>Alberti</surname><given-names>C</given-names></name><name><surname>Titomanlio</surname><given-names>L</given-names></name></person-group><article-title>Association between childhood migraine and history of infantile colic</article-title><source>JAMA</source><year>2013</year><volume>309</volume><fpage>1607</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1001/jama.2013.747</pub-id><?supplied-pmid 23592105?><pub-id pub-id-type="pmid">23592105</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Titomanlio</surname><given-names>L</given-names></name><name><surname>Bargui</surname><given-names>F</given-names></name><name><surname>Gibertini</surname><given-names>GG</given-names></name><name><surname>Siriez</surname><given-names>JY</given-names></name><name><surname>Mercier</surname><given-names>JC</given-names></name></person-group><article-title>Quest for the diagnosis. Case 2: A child with abnormal ocular movements</article-title><source>Acta Paediatr</source><year>2007</year><volume>96</volume><fpage>1097</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.2007.00339.x</pub-id><?supplied-pmid 17577345?><pub-id pub-id-type="pmid">17577345</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>D</given-names></name><name><surname>Tsou</surname><given-names>M</given-names></name><name><surname>McGuire</surname><given-names>E</given-names></name><name><surname>Surran</surname><given-names>B</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><name><surname>Vu</surname><given-names>TA</given-names></name></person-group><article-title>Abdominal migraine: an under-diagnosed cause of recurrent abdominal pain in children</article-title><source>Headache</source><year>2011</year><volume>51</volume><fpage>707</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.01855.x</pub-id><?supplied-pmid 21395574?><pub-id pub-id-type="pmid">21395574</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuomo-Granston</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>PD</given-names></name></person-group><article-title>Migraine and motion sickness: what is the link?</article-title><source>Prog Neurobiol</source><year>2010</year><volume>91</volume><fpage>300</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.04.001</pub-id><?supplied-pmid 20416353?><pub-id pub-id-type="pmid">20416353</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>ND</given-names></name><name><surname>Dholakia</surname><given-names>SY</given-names></name></person-group><article-title>Recurrent limb pain and migraine: case reports and a clinical review</article-title><source>Cephalalgia</source><year>2009</year><volume>29</volume><fpage>898</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01809.x</pub-id><?supplied-pmid 19220300?><pub-id pub-id-type="pmid">19220300</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arruda</surname><given-names>MA</given-names></name><name><surname>Guidetti</surname><given-names>V</given-names></name><name><surname>Galli</surname><given-names>F</given-names></name><name><surname>Albuquerque</surname><given-names>RC</given-names></name><name><surname>Bigal</surname><given-names>ME</given-names></name></person-group><article-title>Childhood periodic syndromes: a population-based study</article-title><source>Pediatr Neurol</source><year>2010</year><volume>43</volume><fpage>420</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2010.06.016</pub-id><?supplied-pmid 21093733?><pub-id pub-id-type="pmid">21093733</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosman</surname><given-names>NP</given-names></name><name><surname>Douglass</surname><given-names>LM</given-names></name><name><surname>Sharif</surname><given-names>UM</given-names></name><name><surname>Paolini</surname><given-names>J</given-names></name></person-group><article-title>The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature</article-title><source>J Child Neurol</source><year>2009</year><volume>24</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1177/0883073808322338</pub-id><?supplied-pmid 19182151?><pub-id pub-id-type="pmid">19182151</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krams</surname><given-names>B</given-names></name><name><surname>Echenne</surname><given-names>B</given-names></name><name><surname>Leydet</surname><given-names>J</given-names></name><name><surname>Rivier</surname><given-names>F</given-names></name><name><surname>Roubertie</surname><given-names>A</given-names></name></person-group><article-title>Benign paroxysmal vertigo of childhood: long-term outcome</article-title><source>Cephalalgia</source><year>2011</year><volume>31</volume><fpage>439</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1177/0333102410382797</pub-id><?supplied-pmid 20851837?><pub-id pub-id-type="pmid">20851837</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelfand</surname><given-names>AA</given-names></name><name><surname>Thomas</surname><given-names>KC</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Before the headache: infant colic as an early life expression of migraine</article-title><source>Neurology</source><year>2012</year><volume>79</volume><fpage>1392</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31826c1b7b</pub-id><?supplied-pmid 22972642?><pub-id pub-id-type="pmid">22972642</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuenca-Leon</surname><given-names>E</given-names></name><name><surname>Corominas</surname><given-names>R</given-names></name><name><surname>Fernandez-Castillo</surname><given-names>N</given-names></name><name><surname>Volpini</surname><given-names>V</given-names></name><name><surname>Del Toro</surname><given-names>M</given-names></name><name><surname>Roig</surname><given-names>M</given-names></name><name><surname>Macaya</surname><given-names>A</given-names></name><name><surname>Cormand</surname><given-names>B</given-names></name></person-group><article-title>Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes</article-title><source>Cephalalgia</source><year>2008</year><volume>28</volume><fpage>1039</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01645.x</pub-id><?supplied-pmid 18644040?><pub-id pub-id-type="pmid">18644040</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessel</surname><given-names>MA</given-names></name><name><surname>Cobb</surname><given-names>JC</given-names></name><name><surname>Jackson</surname><given-names>EB</given-names></name><name><surname>Harris</surname><given-names>GS</given-names><suffix>Jr</suffix></name><name><surname>Detwiler</surname><given-names>AC</given-names></name></person-group><article-title>Paroxysmal fussing in infancy, sometimes called colic</article-title><source>Pediatrics</source><year>1954</year><volume>14</volume><fpage>421</fpage><lpage>435</lpage><?supplied-pmid 13214956?><pub-id pub-id-type="pmid">13214956</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro-Rodriguez</surname><given-names>JA</given-names></name><name><surname>Stern</surname><given-names>DA</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>AL</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Taussig</surname><given-names>LM</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>Relation between infantile colic and asthma/atopy: a prospective study in an unselected population</article-title><source>Pediatrics</source><year>2001</year><volume>108</volume><fpage>878</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1542/peds.108.4.878</pub-id><?supplied-pmid 11581439?><pub-id pub-id-type="pmid">11581439</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucassen</surname><given-names>PL</given-names></name><name><surname>Assendelft</surname><given-names>WJ</given-names></name><name><surname>Van Eijk</surname><given-names>JT</given-names></name><name><surname>Gubbels</surname><given-names>JW</given-names></name><name><surname>Douwes</surname><given-names>AC</given-names></name><name><surname>Van Geldrop</surname><given-names>WJ</given-names></name></person-group><article-title>Systematic review of the occurrence of infantile colic in the community</article-title><source>Arch Dis Child</source><year>2001</year><volume>84</volume><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1136/adc.84.5.398</pub-id><?supplied-pmid 11316682?><pub-id pub-id-type="pmid">11316682</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giffin</surname><given-names>NJ</given-names></name><name><surname>Benton</surname><given-names>S</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation</article-title><source>Dev Med Child Neurol</source><year>2002</year><volume>44</volume><fpage>490</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8749.2002.tb00311.x</pub-id><?supplied-pmid 12162387?><pub-id pub-id-type="pmid">12162387</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basser</surname><given-names>LS</given-names></name></person-group><article-title>Benign Paroxysmal Vertigo of Childhood. (a Variety of Vestibular Neuronitis)</article-title><source>Brain</source><year>1964</year><volume>87</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1093/brain/87.1.141</pub-id><?supplied-pmid 14152207?><pub-id pub-id-type="pmid">14152207</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drigo</surname><given-names>P</given-names></name><name><surname>Carli</surname><given-names>G</given-names></name><name><surname>Laverda</surname><given-names>AM</given-names></name></person-group><article-title>Benign paroxysmal vertigo of childhood</article-title><source>Brain Dev</source><year>2001</year><volume>23</volume><fpage>38</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/S0387-7604(01)00175-9</pub-id><?supplied-pmid 11226728?><pub-id pub-id-type="pmid">11226728</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindskog</surname><given-names>U</given-names></name><name><surname>Odkvist</surname><given-names>L</given-names></name><name><surname>Noaksson</surname><given-names>L</given-names></name><name><surname>Wallquist</surname><given-names>J</given-names></name></person-group><article-title>Benign paroxysmal vertigo in childhood: a long-term follow-up</article-title><source>Headache</source><year>1999</year><volume>39</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.1999.3901033.x</pub-id><?supplied-pmid 15613192?><pub-id pub-id-type="pmid">15613192</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcelli</surname><given-names>V</given-names></name><name><surname>Piazza</surname><given-names>F</given-names></name><name><surname>Pisani</surname><given-names>F</given-names></name><name><surname>Marciano</surname><given-names>E</given-names></name></person-group><article-title>Neuro-otological features of benign paroxysmal vertigo and benign paroxysmal positioning vertigo in children: a follow-up study</article-title><source>Brain Dev</source><year>2006</year><volume>28</volume><fpage>80</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.braindev.2005.05.003</pub-id><?supplied-pmid 16168599?><pub-id pub-id-type="pmid">16168599</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanzi</surname><given-names>G</given-names></name><name><surname>Balottin</surname><given-names>U</given-names></name><name><surname>Fazzi</surname><given-names>E</given-names></name><name><surname>Tagliasacchi</surname><given-names>M</given-names></name><name><surname>Manfrin</surname><given-names>M</given-names></name><name><surname>Mira</surname><given-names>E</given-names></name></person-group><article-title>Benign paroxysmal vertigo of childhood: a long-term follow-up</article-title><source>Cephalalgia</source><year>1994</year><volume>14</volume><fpage>458</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1994.1406458.x</pub-id><?supplied-pmid 7697708?><pub-id pub-id-type="pmid">7697708</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BU</given-names></name><name><surname>Balint</surname><given-names>JP</given-names></name></person-group><article-title>Cyclic vomiting syndrome: evolution in our understanding of a brain-gut disorder</article-title><source>Adv Pediatr</source><year>2000</year><volume>47</volume><fpage>117</fpage><lpage>160</lpage><?supplied-pmid 10959442?><pub-id pub-id-type="pmid">10959442</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BU</given-names></name><name><surname>Lefevre</surname><given-names>F</given-names></name><name><surname>Chelimsky</surname><given-names>GG</given-names></name><name><surname>Boles</surname><given-names>RG</given-names></name><name><surname>Nelson</surname><given-names>SP</given-names></name><name><surname>Lewis</surname><given-names>DW</given-names></name><name><surname>Linder</surname><given-names>SL</given-names></name><name><surname>Issenman</surname><given-names>RM</given-names></name><name><surname>Rudolph</surname><given-names>CD</given-names></name></person-group><article-title>North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2008</year><volume>47</volume><fpage>379</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1097/MPG.0b013e318173ed39</pub-id><?supplied-pmid 18728540?><pub-id pub-id-type="pmid">18728540</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>C</given-names></name><name><surname>Staiano</surname><given-names>A</given-names></name><name><surname>Rothbaum</surname><given-names>RJ</given-names></name><name><surname>Clouse</surname><given-names>RE</given-names></name></person-group><article-title>Similarities in cyclic vomiting syndrome across age groups</article-title><source>Am J Gastroenterol</source><year>2001</year><volume>96</volume><fpage>684</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2001.03606.x</pub-id><?supplied-pmid 11280534?><pub-id pub-id-type="pmid">11280534</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BU</given-names></name><name><surname>Misiewicz</surname><given-names>L</given-names></name></person-group><article-title>Cyclic vomiting syndrome: a brain-gut disorder</article-title><source>Gastroenterol Clin North Am</source><year>2003</year><volume>32</volume><fpage>997</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1016/S0889-8553(03)00045-1</pub-id><?supplied-pmid 14562585?><pub-id pub-id-type="pmid">14562585</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Arafeh</surname><given-names>I</given-names></name><name><surname>Russell</surname><given-names>G</given-names></name></person-group><article-title>Prevalence and clinical features of abdominal migraine compared with those of migraine headache</article-title><source>Arch Dis Child</source><year>1995</year><volume>72</volume><fpage>413</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1136/adc.72.5.413</pub-id><?supplied-pmid 7618907?><pub-id pub-id-type="pmid">7618907</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>V</given-names></name><name><surname>Sahami</surname><given-names>AR</given-names></name><name><surname>Peebles</surname><given-names>R</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name></person-group><article-title>Abdominal migraine and treatment with intravenous valproic Acid</article-title><source>Psychosomatics</source><year>2006</year><volume>47</volume><fpage>353</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1176/appi.psy.47.4.353</pub-id><?supplied-pmid 16844896?><pub-id pub-id-type="pmid">16844896</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>G</given-names></name><name><surname>Abu-Arafeh</surname><given-names>I</given-names></name><name><surname>Symon</surname><given-names>DN</given-names></name></person-group><article-title>Abdominal migraine: evidence for existence and treatment options</article-title><source>Pediatric drugs</source><year>2002</year><volume>4</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2165/00128072-200204010-00001</pub-id><?supplied-pmid 11817981?><pub-id pub-id-type="pmid">11817981</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weydert</surname><given-names>JA</given-names></name><name><surname>Ball</surname><given-names>TM</given-names></name><name><surname>Davis</surname><given-names>MF</given-names></name></person-group><article-title>Systematic review of treatments for recurrent abdominal pain</article-title><source>Pediatrics</source><year>2003</year><volume>111</volume><fpage>e1</fpage><lpage>e11</lpage><pub-id pub-id-type="doi">10.1542/peds.111.1.e1</pub-id><?supplied-pmid 12509588?><pub-id pub-id-type="pmid">12509588</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>MA</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Reeh</surname><given-names>PW</given-names></name><name><surname>Neurath</surname><given-names>MF</given-names></name></person-group><article-title>Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut</article-title><source>Inflamm Bowel Dis</source><year>2011</year><volume>17</volume><fpage>1030</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1002/ibd.21422</pub-id><?supplied-pmid 20722067?><pub-id pub-id-type="pmid">20722067</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>LG</given-names></name><name><surname>Zee</surname><given-names>PC</given-names></name></person-group><article-title>Infantile colic and migraine</article-title><source>JAMA</source><year>2013</year><volume>309</volume><fpage>1636</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1001/jama.2013.3873</pub-id><?supplied-pmid 23592110?><pub-id pub-id-type="pmid">23592110</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abell</surname><given-names>TL</given-names></name><name><surname>Adams</surname><given-names>KA</given-names></name><name><surname>Boles</surname><given-names>RG</given-names></name><name><surname>Bousvaros</surname><given-names>A</given-names></name><name><surname>Chong</surname><given-names>SK</given-names></name><name><surname>Fleisher</surname><given-names>DR</given-names></name><name><surname>Hasler</surname><given-names>WL</given-names></name><name><surname>Hyman</surname><given-names>PE</given-names></name><name><surname>Issenman</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>BU</given-names></name><name><surname>Linder</surname><given-names>SL</given-names></name><name><surname>Mayer</surname><given-names>EA</given-names></name><name><surname>McCallum</surname><given-names>RW</given-names></name><name><surname>Olden</surname><given-names>K</given-names></name><name><surname>Parkman</surname><given-names>HP</given-names></name><name><surname>Rudolph</surname><given-names>CD</given-names></name><name><surname>Tache</surname><given-names>Y</given-names></name><name><surname>Tarbell</surname><given-names>S</given-names></name><name><surname>Vakil</surname><given-names>N</given-names></name></person-group><article-title>Cyclic vomiting syndrome in adults</article-title><source>Neurogastroenterol Motil</source><year>2008</year><volume>20</volume><fpage>269</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2982.2008.01113.x</pub-id><?supplied-pmid 18371009?><pub-id pub-id-type="pmid">18371009</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tache</surname><given-names>Y</given-names></name></person-group><article-title>Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis</article-title><source>Dig Dis Sci</source><year>1999</year><volume>44</volume><fpage>79S</fpage><lpage>86S</lpage><pub-id pub-id-type="doi">10.1023/A:1026602216846</pub-id><?supplied-pmid 10490044?><pub-id pub-id-type="pmid">10490044</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanger</surname><given-names>GJ</given-names></name><name><surname>Andrews</surname><given-names>PL</given-names></name></person-group><article-title>Treatment of nausea and vomiting: gaps in our knowledge</article-title><source>Auton Neurosci</source><year>2006</year><volume>129</volume><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.autneu.2006.07.009</pub-id><?supplied-pmid 16934536?><pub-id pub-id-type="pmid">16934536</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>RC</given-names></name><name><surname>Gardiner</surname><given-names>A</given-names></name><name><surname>Antony</surname><given-names>J</given-names></name><name><surname>Houlden</surname><given-names>H</given-names></name></person-group><article-title>Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine</article-title><source>Dev Med Child Neurol</source><year>2012</year><volume>54</volume><fpage>958</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8749.2012.04394.x</pub-id><?supplied-pmid 22845787?><pub-id pub-id-type="pmid">22845787</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>B</given-names></name><name><surname>Klemm</surname><given-names>E</given-names></name><name><surname>Haverkamp</surname><given-names>F</given-names></name></person-group><article-title>Evidence for altered basal ganglia and cortical functions in transient idiopathic dystonia</article-title><source>J Child Neurol</source><year>2000</year><volume>15</volume><fpage>820</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1177/088307380001501212</pub-id><?supplied-pmid 11198500?><pub-id pub-id-type="pmid">11198500</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakisaka</surname><given-names>Y</given-names></name><name><surname>Wakusawa</surname><given-names>K</given-names></name><name><surname>Haginoya</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Uematsu</surname><given-names>M</given-names></name><name><surname>Yokoyama</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Tsuchiya</surname><given-names>S</given-names></name></person-group><article-title>Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine?</article-title><source>J Child Neurol</source><year>2010</year><volume>25</volume><fpage>234</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1177/0883073809336875</pub-id><?supplied-pmid 19509407?><pub-id pub-id-type="pmid">19509407</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kothare</surname><given-names>SV</given-names></name></person-group><article-title>Efficacy of flunarizine in the prophylaxis of cyclical vomiting syndrome and abdominal migraine</article-title><source>Eur J Paediatr Neurol</source><year>2005</year><volume>9</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ejpn.2004.11.002</pub-id><?supplied-pmid 15701563?><pub-id pub-id-type="pmid">15701563</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>MM</given-names></name><name><surname>Padula</surname><given-names>NA</given-names></name><name><surname>Santos</surname><given-names>LC</given-names></name><name><surname>Oliveira</surname><given-names>LD</given-names></name><name><surname>Agapejev</surname><given-names>S</given-names></name><name><surname>Padovani</surname><given-names>C</given-names></name></person-group><article-title>Critical analysis of the international classification of headache disorders diagnostic criteria (ICHD I-1988) and (ICHD II-2004), for migraine in children and adolescents</article-title><source>Cephalalgia</source><year>2005</year><volume>25</volume><fpage>1042</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2005.00954.x</pub-id><?supplied-pmid 16232155?><pub-id pub-id-type="pmid">16232155</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holstein</surname><given-names>BE</given-names></name><name><surname>Andersen</surname><given-names>A</given-names></name><name><surname>Krolner</surname><given-names>R</given-names></name><name><surname>Due</surname><given-names>P</given-names></name><name><surname>Hansen</surname><given-names>EH</given-names></name></person-group><article-title>Young adolescents&#x02019; use of medicine for headache: sources of supply, availability and accessibility at home</article-title><source>Pharmacoepidemiol Drug Saf</source><year>2008</year><volume>17</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1002/pds.1563</pub-id><?supplied-pmid 18302299?><pub-id pub-id-type="pmid">18302299</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>A</given-names></name><name><surname>Holstein</surname><given-names>BE</given-names></name><name><surname>Due</surname><given-names>P</given-names></name><name><surname>Hansen</surname><given-names>EH</given-names></name></person-group><article-title>Medicine use for headache in adolescence predicts medicine use for headache in young adulthood</article-title><source>Pharmacoepidemiol Drug Saf</source><year>2009</year><volume>18</volume><fpage>619</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1002/pds.1748</pub-id><?supplied-pmid 19358227?><pub-id pub-id-type="pmid">19358227</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>GA</given-names></name><name><surname>Cader</surname><given-names>MZ</given-names></name></person-group><article-title>New directions in migraine</article-title><source>BMC Med</source><year>2011</year><volume>9</volume><fpage>116</fpage><pub-id pub-id-type="doi">10.1186/1741-7015-9-116</pub-id><?supplied-pmid 22027350?><pub-id pub-id-type="pmid">22027350</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eising</surname><given-names>E</given-names></name><name><surname>De Vries</surname><given-names>B</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name></person-group><article-title>Pearls and pitfalls in genetic studies of migraine</article-title><source>Cephalalgia</source><year>2013</year><volume>33</volume><fpage>614</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1177/0333102413484988</pub-id><?supplied-pmid 23671257?><pub-id pub-id-type="pmid">23671257</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Grieco</surname><given-names>GS</given-names></name><name><surname>Santorelli</surname><given-names>FM</given-names></name></person-group><article-title>Migraine headache: a review of the molecular genetics of a common disorder</article-title><source>J Headache Pain</source><year>2012</year><volume>13</volume><fpage>571</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1007/s10194-012-0478-x</pub-id><?supplied-pmid 22940869?><pub-id pub-id-type="pmid">22940869</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eising</surname><given-names>E</given-names></name><name><surname>A Datson</surname><given-names>N</given-names></name><name><surname>Van Den Maagdenberg</surname><given-names>AM</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name></person-group><article-title>Epigenetic mechanisms in migraine: a promising avenue?</article-title><source>BMC Med</source><year>2013</year><volume>11</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/1741-7015-11-26</pub-id><?supplied-pmid 23379668?><pub-id pub-id-type="pmid">23379668</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanzi</surname><given-names>G</given-names></name><name><surname>Zambrino</surname><given-names>CA</given-names></name><name><surname>Ferrari-Ginevra</surname><given-names>O</given-names></name><name><surname>Termine</surname><given-names>C</given-names></name><name><surname>D&#x02019;Arrigo</surname><given-names>S</given-names></name><name><surname>Vercelli</surname><given-names>P</given-names></name><name><surname>De Silvestri</surname><given-names>A</given-names></name><name><surname>Guglielmino</surname><given-names>CR</given-names></name></person-group><article-title>Personality traits in childhood and adolescent headache</article-title><source>Cephalalgia</source><year>2001</year><volume>21</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2001.00144.x</pub-id><?supplied-pmid 11298664?><pub-id pub-id-type="pmid">11298664</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strine</surname><given-names>TW</given-names></name><name><surname>Okoro</surname><given-names>CA</given-names></name><name><surname>McGuire</surname><given-names>LC</given-names></name><name><surname>Balluz</surname><given-names>LS</given-names></name></person-group><article-title>The associations among childhood headaches, emotional and behavioral difficulties, and health care use</article-title><source>Pediatrics</source><year>2006</year><volume>117</volume><fpage>1728</fpage><lpage>1735</lpage><pub-id pub-id-type="doi">10.1542/peds.2005-1024</pub-id><?supplied-pmid 16651331?><pub-id pub-id-type="pmid">16651331</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MS</given-names></name><name><surname>Martin-Herz</surname><given-names>SP</given-names></name><name><surname>Womack</surname><given-names>WM</given-names></name><name><surname>Marsigan</surname><given-names>JL</given-names></name></person-group><article-title>Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine</article-title><source>Pediatrics</source><year>2003</year><volume>111</volume><fpage>e376</fpage><lpage>e381</lpage><pub-id pub-id-type="doi">10.1542/peds.111.4.e376</pub-id><?supplied-pmid 12671155?><pub-id pub-id-type="pmid">12671155</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milde-Busch</surname><given-names>A</given-names></name><name><surname>Boneberger</surname><given-names>A</given-names></name><name><surname>Heinrich</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Kuhnlein</surname><given-names>A</given-names></name><name><surname>Radon</surname><given-names>K</given-names></name><name><surname>Straube</surname><given-names>A</given-names></name><name><surname>Von Kries</surname><given-names>R</given-names></name></person-group><article-title>Higher prevalence of psychopathological symptoms in adolescents with headache. A population-based cross-sectional study</article-title><source>Headache</source><year>2010</year><volume>50</volume><fpage>738</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2009.01605.x</pub-id><?supplied-pmid 20100300?><pub-id pub-id-type="pmid">20100300</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogliani</surname><given-names>L</given-names></name><name><surname>Spiri</surname><given-names>D</given-names></name><name><surname>Penagini</surname><given-names>F</given-names></name><name><surname>Nello</surname><given-names>FD</given-names></name><name><surname>Duca</surname><given-names>P</given-names></name><name><surname>Zuccotti</surname><given-names>GV</given-names></name></person-group><article-title>Headache in children and adolescents aged 6-18 years in northern Italy: prevalence and risk factors</article-title><source>Eur J Paediatr Neurol</source><year>2011</year><volume>15</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.ejpn.2010.11.005</pub-id><?supplied-pmid 21177128?><pub-id pub-id-type="pmid">21177128</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margari</surname><given-names>F</given-names></name><name><surname>Lucarelli</surname><given-names>E</given-names></name><name><surname>Craig</surname><given-names>F</given-names></name><name><surname>Petruzzelli</surname><given-names>MG</given-names></name><name><surname>Lecce</surname><given-names>PA</given-names></name><name><surname>Margari</surname><given-names>L</given-names></name></person-group><article-title>Psychopathology in children and adolescents with primary headaches: Categorical and dimensional approaches</article-title><source>Cephalalgia</source><year>2013</year><volume>33</volume><fpage>1311</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1177/0333102413495966</pub-id><?supplied-pmid 23827982?><pub-id pub-id-type="pmid">23827982</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Powers</surname><given-names>SW</given-names></name><name><surname>Vockell</surname><given-names>AL</given-names></name><name><surname>LeCates</surname><given-names>S</given-names></name><name><surname>Kabbouche</surname><given-names>MA</given-names></name><name><surname>Maynard</surname><given-names>MK</given-names></name></person-group><article-title>PedMIDAS: development of a questionnaire to assess disability of migraines in children</article-title><source>Neurology</source><year>2001</year><volume>57</volume><fpage>2034</fpage><lpage>2039</lpage><pub-id pub-id-type="doi">10.1212/WNL.57.11.2034</pub-id><?supplied-pmid 11739822?><pub-id pub-id-type="pmid">11739822</pub-id></element-citation></ref></ref-list></back></article>